<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:33:52Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8601451" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8601451</identifier>
        <datestamp>2021-11-19</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8601451</article-id>
              <article-id pub-id-type="pmcid">PMC8601451</article-id>
              <article-id pub-id-type="pmc-uid">8601451</article-id>
              <article-id pub-id-type="pmid">34793552</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0260107</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-21-20128</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Clinical Medicine</subject>
                    <subj-group>
                      <subject>Signs and Symptoms</subject>
                      <subj-group>
                        <subject>Hemorrhage</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Hemorrhage</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Medical Risk Factors</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Cardiovascular Diseases</subject>
                      <subj-group>
                        <subject>Cardiovascular Disease Risk</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Cardiology</subject>
                    <subj-group>
                      <subject>Cardiovascular Medicine</subject>
                      <subj-group>
                        <subject>Cardiovascular Diseases</subject>
                        <subj-group>
                          <subject>Cardiovascular Disease Risk</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Political Science</subject>
                    <subj-group>
                      <subject>Public Policy</subject>
                      <subj-group>
                        <subject>Medicare</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pharmacology</subject>
                    <subj-group>
                      <subject>Drugs</subject>
                      <subj-group>
                        <subject>Antihypertensive Drugs</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and health sciences</subject>
                  <subj-group>
                    <subject>Pharmaceutics</subject>
                    <subj-group>
                      <subject>Drug therapy</subject>
                      <subj-group>
                        <subject>Cardiovascular therapy</subject>
                        <subj-group>
                          <subject>ACE inhibitor therapy</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Endocrinology</subject>
                    <subj-group>
                      <subject>Endocrine Disorders</subject>
                      <subj-group>
                        <subject>Diabetes Mellitus</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Metabolic Disorders</subject>
                      <subj-group>
                        <subject>Diabetes Mellitus</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pharmaceutics</subject>
                    <subj-group>
                      <subject>Drug Therapy</subject>
                      <subj-group>
                        <subject>Cardiovascular Therapy</subject>
                        <subj-group>
                          <subject>Antihypertensive Drug Therapy</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker</article-title>
                <alt-title alt-title-type="running-head">Risk of GI bleeding in ALLHAT</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0119-5252</contrib-id>
                  <name>
                    <surname>Du</surname>
                    <given-names>Xianglin L.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Simpson</surname>
                    <given-names>Lara M.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tandy</surname>
                    <given-names>Brian C.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bettencourt</surname>
                    <given-names>Judith L.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Davis</surname>
                    <given-names>Barry R.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Coordinating Center for Clinical Trials, Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Wright</surname>
                    <given-names>James M.</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>University of British Columbia, CANADA</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>Xianglin.L.Du@uth.tmc.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>18</day>
                <month>11</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>16</volume>
              <issue>11</issue>
              <elocation-id>e0260107</elocation-id>
              <history>
                <date date-type="received">
                  <day>18</day>
                  <month>6</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>2</day>
                  <month>11</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 Du et al</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Du et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0260107.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Objectives</title>
                  <p>This post-trial data linkage analysis was to utilize the data of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants linked with their Medicare data to examine the risk of hospitalized and non-hospitalized gastrointestinal (GI) bleeding associated with antihypertensives.</p>
                </sec>
                <sec id="sec002">
                  <title>Settings</title>
                  <p>ALLHAT was a multicenter, randomized, double-blind, active-controlled trial conducted in a total of 42,418 participants aged ≥55 years with hypertension in 623 North American centers. Data for ALLHAT participants who were aged at ≥65 have been linked with their Medicare claims data.</p>
                </sec>
                <sec id="sec003">
                  <title>Participants</title>
                  <p>A total of 16,676 patients (4,480 for lisinopril, 4,537 for amlodipine, and 7,659 for chlorthalidone) with complete Medicare claims data were available for the final analysis.</p>
                </sec>
                <sec id="sec004">
                  <title>Results</title>
                  <p>The cumulative incidences through March 31, 2002 of hospitalized GI bleeding were 5.4%, 5.8% and 5.4% for amlodipine, lisinopril, and chlorthalidone arms, respectively, but were not statistically significant among the 3 arms after adjusting for confounders in Cox regression models. The cumulative incidences of non-hospitalized GI bleeding were also similar across the 3 arms (12.0%, 12.2% and 12.0% for amlodipine, lisinopril, and chlorthalidone, respectively). The increased risk of GI bleeding by age was statistically significant after adjusting for confounders (HR = 1.04 per year, 95% CI: 1.03–1.05). Smokers also had a significantly higher risk of having hospitalized GI bleeding (1.45, 1.19–1.76). Hispanics, those who used aspirin or atenolol in-trial, had diabetes, more education, and a history of stroke had a significantly lower risk of having GI bleeding than their counterparts. Other factors such as gender, history of CHD, prior antihypertensive use, use of estrogen in women, and obesity did not have significant effects on the risk of GI bleeding.</p>
                </sec>
                <sec id="sec005">
                  <title>Conclusion</title>
                  <p>There were no statistically significant differences on the risk of hospitalized or non-hospitalized GI bleeding among the 3 ALLHAT trial arms (amlodipine, lisinopril, and chlorthalidone) during the entire in-trial follow-up.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
                      <institution>National Institute on Aging</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01AG058971</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0119-5252</contrib-id>
                    <name>
                      <surname>Du</surname>
                      <given-names>Xianglin L.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This study was supported by the National Institutes of Health (NIH) grant Number R01AG058971 (PI: Dr. Du; Co-I’s: Dr. Davis and Dr. Simpson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="0"/>
                <table-count count="5"/>
                <page-count count="15"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>The ALLHAT data, Medicare claims data, Medicare Part-D and National Death Index (NDI) data are not public-use datasets. These are third party data. All researchers would be able to access these data in the following same manner as the authors: researchers may request the ALLHAT data with the approval from the ALLHAT Coordinating Center in Houston, the Medicare claims data and Medicare Part-D data with the approval from the Center for Medicare and Medicaid Services (CMS), and the National Death Index (NDI) data with the approval from the National Center for Health Statistics (NCHS). We confirm that the authors did not have any special access privileges that others would not have. We plan to share the statistical models and statistical programs that we used to analyze these data upon request. Here are statistical models on the Kaplan-Meier estimates and Cox regressions using STATA software: 1). Kaplan Meier estimates on the cumulative incidence of GI bleeding: sts list, by(Group) failure at(0 1 2 3 4 5 6) 2). Cox regressions on the hazard ratio of GI bleeding: stset Outcomeyear if Outcome &lt;., failure(Outcome) stcox GroupComparison.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>The ALLHAT data, Medicare claims data, Medicare Part-D and National Death Index (NDI) data are not public-use datasets. These are third party data. All researchers would be able to access these data in the following same manner as the authors: researchers may request the ALLHAT data with the approval from the ALLHAT Coordinating Center in Houston, the Medicare claims data and Medicare Part-D data with the approval from the Center for Medicare and Medicaid Services (CMS), and the National Death Index (NDI) data with the approval from the National Center for Health Statistics (NCHS). We confirm that the authors did not have any special access privileges that others would not have. We plan to share the statistical models and statistical programs that we used to analyze these data upon request. Here are statistical models on the Kaplan-Meier estimates and Cox regressions using STATA software: 1). Kaplan Meier estimates on the cumulative incidence of GI bleeding: sts list, by(Group) failure at(0 1 2 3 4 5 6) 2). Cox regressions on the hazard ratio of GI bleeding: stset Outcomeyear if Outcome &lt;., failure(Outcome) stcox GroupComparison.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec006">
              <title>Introduction</title>
              <p>Calcium channel blockers (CCB)s have been well documented to be efficacious in treating patients with hypertension [<xref rid="pone.0260107.ref001" ref-type="bibr">1</xref>–<xref rid="pone.0260107.ref010" ref-type="bibr">10</xref>]. However, there were some concerns about potential risk of gastrointestinal (GI) bleeding associated with the use of CCBs in treating patients with hypertension in a prospective cohort study [<xref rid="pone.0260107.ref011" ref-type="bibr">11</xref>] and in three other observational studies [<xref rid="pone.0260107.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0260107.ref014" ref-type="bibr">14</xref>], whereas other case-control and retrospective cohort studies found no significant association between CCB and risk of GI bleeding [<xref rid="pone.0260107.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0260107.ref019" ref-type="bibr">19</xref>]. A large clinical trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), did not find a significant association between CCB (amlodipine) or angiotensin-converting enzyme (ACE) inhibitor (lisinopril) versus thiazide diuretic (chlorthalidone) and the risk of GI bleeding [<xref rid="pone.0260107.ref020" ref-type="bibr">20</xref>]. A later ALLHAT report of the <italic toggle="yes">post-hoc</italic> comparison of amlodipine with ACE inhibitor lisinopril found a significantly lower risk of GI bleeding in those receiving CCB [<xref rid="pone.0260107.ref021" ref-type="bibr">21</xref>]. A more recent ALLHAT study specifically focusing on the risk of hospitalized GI bleeding in association with various antihypertensive drugs concluded that hypertensive patients on amlodipine did not have an increased risk of GI bleeding compared to those in chlorthalidone or lisinopril arms [<xref rid="pone.0260107.ref022" ref-type="bibr">22</xref>]. Because previous reports were based on patients’ Medicare or Veteran Affairs (VA) data up to September 24, 2001 while the ALLHAT’s last in-trial follow-up data was completed on March 31, 2002, the estimate for the risk of GI bleeding would be more accurate if their last follow-up for capturing GI bleeding from Medicare claims was also completed on March 31, 2002. We have now linked the data of ALLHAT participants with their Medicare data through the entire in-trial period, and hence the data enabled us to both update the analysis of hospitalized GI bleeding to the end of in-trial follow-up and examine the risk of GI bleeding. Moreover, we also examined the risk of non-hospitalized GI bleeding associated with antihypertensive drugs, which has never been reported before among ALLHAT trial participants. This is critically important because not all patients with GI bleeding were to be hospitalized, and therefore there was a concern about underreporting of overall GI bleeding based on hospitalizations alone. Hence, the findings of this study should have high public health and clinical significance with respect to GI bleeding and routine intake of antihypertensive drugs.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec007">
              <title>Methods</title>
              <sec id="sec008">
                <title>Study population and data sources</title>
                <p>The detailed methods of ALLHAT have been reported previously [<xref rid="pone.0260107.ref020" ref-type="bibr">20</xref>–<xref rid="pone.0260107.ref022" ref-type="bibr">22</xref>]. In brief, ALLHAT was a multicenter, randomized, double-blind, active-controlled trial conducted in a total of 42,418 participants aged 55 years or older with hypertension and at least 1 other coronary heart disease (CHD) risk factor in 623 North American centers. Those patients who were eligible and agreed to participate were randomly assigned to 4 treatment arms: an angiotensin-converting enzyme (ACE) inhibitor (lisinopril) (n = 9,054), calcium channel blocker (amlodipine) (n = 9,048), α-blocker (doxazosin) (n = 9,061), or a thiazide-type diuretic (chlorthalidone) (n = 15,255). The primary outcome was the incidence of combined fatal CHD or nonfatal myocardial infarction. Secondary outcomes were all-cause mortality, combined CHD-specific mortality and combined cardiovascular disease (CVD) (combined CHD, stroke, and heart failure [HF]) mortality. This trial’s recruitment period was from February 1, 1994 to January 31, 1998 with the last date of active in-trial follow-up on March 31, 2002. Average follow-up was 4.9 years (ranging from 4 to 8 years) in all arms except for doxazosin-chlorthalidone comparison which was terminated early with a mean follow-up of 3.2 years due to a higher incidence of CVD events. Therefore, this study did not include those patients on doxazosin. We recently obtained the ALLHAT-Medicare linked data in order to study the long-term benefits and harms of antihypertensive drugs, in which our secondary outcome is to examine short and long-term side effects on GI bleeding associated with the use of antihypertensive drugs. Due to potential changing patterns of antihypertensive drug uses after the trial ended to the present time, this report only focused on the short-term side effect of GI bleeding through the end of in-trial period. Data for ALLHAT participants who were aged 65 or older have been linked with their Medicare claims data for the entire in-trial period from January 1, 1994 to March 31, 2002. Of a total of 33,357 participants (9,054 for lisinopril, 9,048 for amlodipine, and 15,255 for chlorthalidone), 553 participants were excluded due to randomization in Canada, 11,960 participants were excluded because of not being eligible for Medicare at their entry to the trial, and 4,168 participants were excluded because of their randomization in the Veteran Affairs (VA) system to which we did not have access to long-term follow-up, leaving 16,676 patients (4,480 for lisinopril, 4,537 for amlodipine, and 7,659 for chlorthalidone) with complete Medicare claims data in the final analysis for this study.</p>
              </sec>
              <sec id="sec009">
                <title>Patient and public involvement statement</title>
                <p>Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of our research.</p>
              </sec>
              <sec id="sec010">
                <title>Ethics statement</title>
                <p>This study was to use the existing and de-identified ALLHAT-Medicare linked datasets and there was no patient contact, therefore the form of consent was not obtained. There is no health risk to the subjects under study. This post-trial data linkage analysis was approved by the Committee for Protection of Human Subjects at the University of Texas Health Science Center in Houston (Study ID: HSC-SPH-17-1035).</p>
              </sec>
              <sec id="sec011">
                <title>Study variables, main exposure and outcomes</title>
                <p>Main exposure for the study were antihypertensive drugs (lisinopril, amlodipine, and chlorthalidone) which were allocated to participants through randomization. Main outcomes of this study included the occurrence of hospitalized and non-hospitalized GI bleeding. Because the information on hospitalized and non-hospitalized GI bleeding as secondary outcomes was not collected in ALLHAT centers or clinics, we obtained the linked Medicare claims data from the Center for Medicare and Medicaid Services (CMS) for the ALLHAT participants. We searched Medicare claims through March 31, 2002 as the last date of in-trial follow-up in order to ascertain the risk of GI bleeding during the entire in-trial period. The occurrence of hospitalized GI bleeding was identified through the inpatient hospitalization files using ICD-9 or ICD-10 codes (<xref rid="pone.0260107.s001" ref-type="supplementary-material">S1 Table</xref>). The occurrence of non-hospitalized GI bleeding was identified through the outpatient files or from physician office visit files using the ICD-9 or ICD-10 codes. These outcomes were compared among subjects in 3 arms who received lisinopril, amlodipine, or chlorthalidone.</p>
                <p>ALLHAT baseline demographic and clinical data were incorporated into analyses, including age, race, ethnicity, gender, prior receipt of antihypertensive drug therapy, blood pressure (BP), body mass index, history of coronary heart disease, aspirin and estrogen use, cigarette smoking, history of atherosclerotic cardiovascular disease, history of myocardial infarction or stroke, history of coronary revascularization, history of other atherosclerotic cardiovascular disease, ST-T wave, HDL-cholesterol &lt;35 mg/dL, LVH (left ventricular hypertrophy) by ECG or echocardiography, LVH by Minnesota code, and diabetes.</p>
              </sec>
              <sec id="sec012">
                <title>Statistical analysis</title>
                <p>Baseline characteristics among the study comparison groups were compared using chi-square statistics. Cumulative incidence (probability) of GI bleeding were calculated from the date of initial randomization to the end of in-trial follow-up (3/31/2002). Cumulative incidence of GI bleeding was calculated using Kaplan-Meier method and presented in number of GI bleeding cases per 100 persons and per 1,000 persons. In addition, Cox regression models were used to perform the time to event analysis to determine the risk of developing GI bleeding by the 3 in-trial antihypertensive drugs while adjusting for confounding factors. The proportionality assumption was assessed by checking whether the log-log Kaplan-Meier curves are parallel and do not intersect and also by adding an interaction term between antihypertensive medication and time variables to the Cox models. In these models, the interactions between the 3 in-trial antihypertensive drugs and other factors (e.g., age, gender, race, aspirin use, and smoking status) on the risk of GI bleeding were tested and the results with p values were presented.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec013">
              <title>Results</title>
              <p><xref rid="pone.0260107.t001" ref-type="table">Table 1</xref> presents the comparison of baseline characteristics among the 3 trial arms (lisinopril, amlodipine, and chlorthalidone). Of a total of 16,676 subjects who were eligible by the end of in-trial follow-up on 3/31/2002, the baseline characteristics such as age, gender, race/ethnicity, prior receipt of antihypertensive drug therapy, blood pressure, history of coronary heart disease, aspirin and estrogen use, cigarette smoking, history of atherosclerotic cardiovascular disease, history of myocardial infarction or stroke, history of coronary revascularization, history of other atherosclerotic cardiovascular disease, left ventricular hypertrophy, diabetes and obesity are generally similar among the 3 trial arms (lisinopril, amlodipine, and chlorthalidone).</p>
              <table-wrap position="float" id="pone.0260107.t001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0260107.t001</object-id>
                <label>Table 1</label>
                <caption>
                  <title>Baseline characteristics of participants by randomized treatment arms.</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0260107.t001" id="pone.0260107.t001g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="justify" rowspan="1" colspan="1">Characteristics</th>
                        <th align="center" colspan="4" rowspan="1">Participants, No (%)</th>
                        <th align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <th align="justify" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">Chlorthalidone</th>
                        <th align="center" rowspan="1" colspan="1">Amlodipine</th>
                        <th align="center" rowspan="1" colspan="1">Lisinopril</th>
                        <th align="center" rowspan="1" colspan="1">Total</th>
                        <th align="center" rowspan="1" colspan="1">P value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Eligible number of participants</td>
                        <td align="center" rowspan="1" colspan="1">7,659</td>
                        <td align="center" rowspan="1" colspan="1">4,537</td>
                        <td align="center" rowspan="1" colspan="1">4,480</td>
                        <td align="center" rowspan="1" colspan="1">16,676</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Age, mean [range], years</td>
                        <td align="center" rowspan="1" colspan="1">71.3 [55–110]</td>
                        <td align="center" rowspan="1" colspan="1">71.3 [55–101]</td>
                        <td align="center" rowspan="1" colspan="1">71.5 [55–98]</td>
                        <td align="center" rowspan="1" colspan="1">71.4 [55–110]</td>
                        <td align="center" rowspan="1" colspan="1">0.467</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        55–64</td>
                        <td align="center" rowspan="1" colspan="1">656 (8.6)</td>
                        <td align="center" rowspan="1" colspan="1">408 (9.0)</td>
                        <td align="center" rowspan="1" colspan="1">374 (8.3)</td>
                        <td align="center" rowspan="1" colspan="1">1438 (8.6)</td>
                        <td align="center" rowspan="1" colspan="1">0.854</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        65–69</td>
                        <td align="center" rowspan="1" colspan="1">2656 (34.7)</td>
                        <td align="center" rowspan="1" colspan="1">1571 (34.6)</td>
                        <td align="center" rowspan="1" colspan="1">1549 (34.6)</td>
                        <td align="center" rowspan="1" colspan="1">5776 (34.6)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        70 or older</td>
                        <td align="center" rowspan="1" colspan="1">4347 (56.8)</td>
                        <td align="center" rowspan="1" colspan="1">2558 (56.4)</td>
                        <td align="center" rowspan="1" colspan="1">2557 (57.1)</td>
                        <td align="center" rowspan="1" colspan="1">9462 (56.7)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Sex</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Women</td>
                        <td align="center" rowspan="1" colspan="1">4383 (57.2)</td>
                        <td align="center" rowspan="1" colspan="1">2581 (56.9)</td>
                        <td align="center" rowspan="1" colspan="1">2489 (55.6)</td>
                        <td align="center" rowspan="1" colspan="1">9453 (56.7)</td>
                        <td align="center" rowspan="1" colspan="1">0.191</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Men</td>
                        <td align="center" rowspan="1" colspan="1">3276 (42.8)</td>
                        <td align="center" rowspan="1" colspan="1">1956 (43.1)</td>
                        <td align="center" rowspan="1" colspan="1">1991 (44.4)</td>
                        <td align="center" rowspan="1" colspan="1">7223 (43.3)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Race/ethnicity</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Black</td>
                        <td align="center" rowspan="1" colspan="1">2694 (35.2)</td>
                        <td align="center" rowspan="1" colspan="1">1615 (35.6)</td>
                        <td align="center" rowspan="1" colspan="1">1560 (34.8)</td>
                        <td align="center" rowspan="1" colspan="1">5869 (35.2)</td>
                        <td align="center" rowspan="1" colspan="1">0.742</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Non-Black</td>
                        <td align="center" rowspan="1" colspan="1">4965 (64.8)</td>
                        <td align="center" rowspan="1" colspan="1">2922 (64.4)</td>
                        <td align="center" rowspan="1" colspan="1">2920 (65.2)</td>
                        <td align="center" rowspan="1" colspan="1">10807 (64.8)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Hispanic ethnicity</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Hispanic</td>
                        <td align="center" rowspan="1" colspan="1">1653 (21.7)</td>
                        <td align="center" rowspan="1" colspan="1">965 (21.4)</td>
                        <td align="center" rowspan="1" colspan="1">1006 (22.6)</td>
                        <td align="center" rowspan="1" colspan="1">3624 (21.8)</td>
                        <td align="center" rowspan="1" colspan="1">0.367</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Non-Hispanic</td>
                        <td align="center" rowspan="1" colspan="1">5966 (78.3)</td>
                        <td align="center" rowspan="1" colspan="1">3545 (78.6)</td>
                        <td align="center" rowspan="1" colspan="1">3451 (77.4)</td>
                        <td align="center" rowspan="1" colspan="1">12962 (78.2)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Education, mean (SD), years<xref rid="t001fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">10.3 (4.2)</td>
                        <td align="center" rowspan="1" colspan="1">10.4 (4.2)</td>
                        <td align="center" rowspan="1" colspan="1">10.3 (4.3)</td>
                        <td align="center" rowspan="1" colspan="1">10.3 (4.2)</td>
                        <td align="center" rowspan="1" colspan="1">0.042</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Antihypertensive treatment</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Treated (prior to baseline)</td>
                        <td align="center" rowspan="1" colspan="1">6926 (90.4)</td>
                        <td align="center" rowspan="1" colspan="1">4128 (91.0)</td>
                        <td align="center" rowspan="1" colspan="1">4089 (91.3)</td>
                        <td align="center" rowspan="1" colspan="1">15143 (90.8)</td>
                        <td align="center" rowspan="1" colspan="1">0.278</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Untreated</td>
                        <td align="center" rowspan="1" colspan="1">732 (9.6)</td>
                        <td align="center" rowspan="1" colspan="1">409 (9.0)</td>
                        <td align="center" rowspan="1" colspan="1">391 (8.7)</td>
                        <td align="center" rowspan="1" colspan="1">1532 (9.2)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Aspirin use at baseline<xref rid="t001fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Yes aspirin used</td>
                        <td align="center" rowspan="1" colspan="1">2694 (35.7)</td>
                        <td align="center" rowspan="1" colspan="1">1594 (35.6)</td>
                        <td align="center" rowspan="1" colspan="1">1624 (36.8)</td>
                        <td align="center" rowspan="1" colspan="1">5912 (36.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.428</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Women taking estrogen<xref rid="t001fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">599 (13.9)</td>
                        <td align="center" rowspan="1" colspan="1">340 (13.4)</td>
                        <td align="center" rowspan="1" colspan="1">322 (13.2)</td>
                        <td align="center" rowspan="1" colspan="1">1261 (13.6)</td>
                        <td align="center" rowspan="1" colspan="1">0.649</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    HDL, mean (SD), mg/dl</td>
                        <td align="center" rowspan="1" colspan="1">48.2 (15.0)</td>
                        <td align="center" rowspan="1" colspan="1">48.6 (15.1)</td>
                        <td align="center" rowspan="1" colspan="1">47.9 (14.7)</td>
                        <td align="center" rowspan="1" colspan="1">48.2 (14.9)</td>
                        <td align="center" rowspan="1" colspan="1">0.262</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    HDL &lt;35 mg/dl</td>
                        <td align="center" rowspan="1" colspan="1">776 (10.1)</td>
                        <td align="center" rowspan="1" colspan="1">490 (10.8)</td>
                        <td align="center" rowspan="1" colspan="1">465 (10.4)</td>
                        <td align="center" rowspan="1" colspan="1">1731 (10.4)</td>
                        <td align="center" rowspan="1" colspan="1">0.505</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Diabetes classification<xref rid="t001fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Diabetic</td>
                        <td align="center" rowspan="1" colspan="1">3045 (43.1)</td>
                        <td align="center" rowspan="1" colspan="1">1827 (43.7)</td>
                        <td align="center" rowspan="1" colspan="1">1788 (43.3)</td>
                        <td align="center" rowspan="1" colspan="1">6660 (43.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.837</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Non-diabetic</td>
                        <td align="center" rowspan="1" colspan="1">4020 (56.9)</td>
                        <td align="center" rowspan="1" colspan="1">2356 (56.3)</td>
                        <td align="center" rowspan="1" colspan="1">2342 (56.7)</td>
                        <td align="center" rowspan="1" colspan="1">8718 (56.7)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Cigarette smoking</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Smoker (current)</td>
                        <td align="center" rowspan="1" colspan="1">1283 (16.8)</td>
                        <td align="center" rowspan="1" colspan="1">772 (17.0)</td>
                        <td align="center" rowspan="1" colspan="1">722 (16.1)</td>
                        <td align="center" rowspan="1" colspan="1">2777 (16.7)</td>
                        <td align="center" rowspan="1" colspan="1">0.496</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Nonsmoker (non/former)</td>
                        <td align="center" rowspan="1" colspan="1">6376 (83.2)</td>
                        <td align="center" rowspan="1" colspan="1">3765 (83.0)</td>
                        <td align="center" rowspan="1" colspan="1">3757 (83.9)</td>
                        <td align="center" rowspan="1" colspan="1">13898 (83.3)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    History of CHD<xref rid="t001fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">2105 (27.7)</td>
                        <td align="center" rowspan="1" colspan="1">1180 (26.2)</td>
                        <td align="center" rowspan="1" colspan="1">1208 (27.2)</td>
                        <td align="center" rowspan="1" colspan="1">4493 (27.1)</td>
                        <td align="center" rowspan="1" colspan="1">0.211</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Atherosclerotic CVD (yes if any of 4 below)</td>
                        <td align="center" rowspan="1" colspan="1">4356 (56.9)</td>
                        <td align="center" rowspan="1" colspan="1">2471 (54.5)</td>
                        <td align="center" rowspan="1" colspan="1">2549 (56.9)</td>
                        <td align="center" rowspan="1" colspan="1">9376 (56.2)</td>
                        <td align="center" rowspan="1" colspan="1">0.020</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        History MI or stroke</td>
                        <td align="center" rowspan="1" colspan="1">1931 (25.2)</td>
                        <td align="center" rowspan="1" colspan="1">1124 (24.8)</td>
                        <td align="center" rowspan="1" colspan="1">1081 (24.1)</td>
                        <td align="center" rowspan="1" colspan="1">4136 (24.8)</td>
                        <td align="center" rowspan="1" colspan="1">0.411</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">        History coronary revascularization</td>
                        <td align="center" rowspan="1" colspan="1">1085 (14.2)</td>
                        <td align="center" rowspan="1" colspan="1">567 (12.5)</td>
                        <td align="center" rowspan="1" colspan="1">663 (14.8)</td>
                        <td align="center" rowspan="1" colspan="1">2315 (13.9)</td>
                        <td align="center" rowspan="1" colspan="1">0.004</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        Other atherosclerotic CVD</td>
                        <td align="center" rowspan="1" colspan="1">2091 (27.3)</td>
                        <td align="center" rowspan="1" colspan="1">1213 (26.7)</td>
                        <td align="center" rowspan="1" colspan="1">1246 (27.8)</td>
                        <td align="center" rowspan="1" colspan="1">4550 (27.3)</td>
                        <td align="center" rowspan="1" colspan="1">0.327</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">        ST-T wave</td>
                        <td align="center" rowspan="1" colspan="1">809 (10.6)</td>
                        <td align="center" rowspan="1" colspan="1">456 (10.1)</td>
                        <td align="center" rowspan="1" colspan="1">480 (10.8)</td>
                        <td align="center" rowspan="1" colspan="1">1745 (10.5)</td>
                        <td align="center" rowspan="1" colspan="1">0.549</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    LVH by Minnesota code</td>
                        <td align="center" rowspan="1" colspan="1">348 (5.4)</td>
                        <td align="center" rowspan="1" colspan="1">217 (5.7)</td>
                        <td align="center" rowspan="1" colspan="1">210 (5.6)</td>
                        <td align="center" rowspan="1" colspan="1">775 (5.5)</td>
                        <td align="center" rowspan="1" colspan="1">0.805</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    SBP, mean (SD), mmHg</td>
                        <td align="center" rowspan="1" colspan="1">146.4 (13.0)</td>
                        <td align="center" rowspan="1" colspan="1">146.3 (13.1)</td>
                        <td align="center" rowspan="1" colspan="1">146.7 (12.8)</td>
                        <td align="center" rowspan="1" colspan="1">146.5 (13.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.523</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    DBP, mean (SD), mmHg</td>
                        <td align="center" rowspan="1" colspan="1">82.8 (9.0)</td>
                        <td align="center" rowspan="1" colspan="1">82.7 (9.1)</td>
                        <td align="center" rowspan="1" colspan="1">82.6 (9.1)</td>
                        <td align="center" rowspan="1" colspan="1">82.7 (9.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.855</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    BMI, mean (SD), mg/kg<sup>2</sup></td>
                        <td align="center" rowspan="1" colspan="1">29.1 (6.1)</td>
                        <td align="center" rowspan="1" colspan="1">29.1 (6.0)</td>
                        <td align="center" rowspan="1" colspan="1">29.3 (6.1)</td>
                        <td align="center" rowspan="1" colspan="1">29.2 (6.1)</td>
                        <td align="center" rowspan="1" colspan="1">0.270</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Obesity</td>
                        <td align="center" rowspan="1" colspan="1">2897 (37.9)</td>
                        <td align="center" rowspan="1" colspan="1">1718 (38.0)</td>
                        <td align="center" rowspan="1" colspan="1">1740 (39.0)</td>
                        <td align="center" rowspan="1" colspan="1">6355 (38.2)</td>
                        <td align="center" rowspan="1" colspan="1">0.492</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lipid trial participants</td>
                        <td align="center" rowspan="1" colspan="1">1851 (24.2)</td>
                        <td align="center" rowspan="1" colspan="1">1072 (23.6)</td>
                        <td align="center" rowspan="1" colspan="1">1028 (22.9)</td>
                        <td align="center" rowspan="1" colspan="1">3951 (23.7)</td>
                        <td align="center" rowspan="1" colspan="1">0.309</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t001fn001">
                    <p>*Reduced denominator Chlorthalidone/Amlodipine/Lisinopril available for Aspirin: C = 7543/A = 4482/L = 4419; BMI: C = 7636/A = 4519/L = 4464; Diabetes: C = 7065/A = 4183/L = 4419; Education: C = 7053/A = 4172/L = 4112; Estrogen: C = 4296/A = 2541/L = 2439; HDL: C = 7265/A = 4277/L = 4224; History of CHD: C = 7612/A = 4507/L = 4449.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p><xref rid="pone.0260107.t002" ref-type="table">Table 2</xref> presents the cumulative incidence of hospitalized GI bleeding, non-hospitalized GI bleeding, and combined all GI bleeding (hospitalized or non-hospitalized GI bleeding) over the entire in-trial follow-up period from February 1, 1994 to March 31, 2002, by 3 RCT arms. The cumulative incidence of hospitalized GI bleeding was 5.4%, 5.8% and 5.4% for amlodipine, lisinopril, and chlorthalidone arms, respectively. Although the cumulative incidence of GI bleeding was slightly lower in patients with amlodipine as compared to those with lisinopril, it was not statistically significant after adjusting for measured confounders in the time to event Cox regression models (<xref rid="pone.0260107.t003" ref-type="table">Table 3</xref>). The cumulative incidence of non-hospitalized GI bleeding was higher than that of hospitalized GI bleeding, but was similar across the 3 arms (12.0%, 12.2% and 12.0% for amlodipine, lisinopril, and chlorthalidone arms, respectively). The cumulative incidence of combined all GI bleeding (hospitalized or non-hospitalized GI bleeding) was also similar across the 3 arms (13.7%, 14.4% and 14.0% for amlodipine, lisinopril, and chlorthalidone arms, respectively) (<xref rid="pone.0260107.t002" ref-type="table">Table 2</xref>) and was not statistically significantly different among the 3 groups after adjusting for confounders in multiple Cox regression models (<xref rid="pone.0260107.t003" ref-type="table">Table 3</xref>). For example, the hazard ratios of having GI bleeding in those receiving chlorthalidone and lisinopril were 1.05 (95% CI: 0.95–1.16) and 1.01 (0.91–1.13) respectively as compared to those receiving amlodipine, whereas the hazard ratio of GI bleeding was 0.97 (0.88–1.07) in those receiving lisinopril as compared to subjects receiving chlorthalidone (<xref rid="pone.0260107.t003" ref-type="table">Table 3</xref>).</p>
              <table-wrap position="float" id="pone.0260107.t002">
                <object-id pub-id-type="doi">10.1371/journal.pone.0260107.t002</object-id>
                <label>Table 2</label>
                <caption>
                  <title>Cumulative incidence of hospitalized GI bleeding, non-hospitalized GI bleeding, and combined all GI bleeding in-trial from 1994 through 3/31/2002.</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0260107.t002" id="pone.0260107.t002g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="justify" rowspan="2" colspan="1"/>
                        <th align="center" colspan="2" rowspan="1">Hospitalized GI Bleeding</th>
                        <th align="center" colspan="2" rowspan="1">Non-hospitalized GI Bleeding</th>
                        <th align="center" colspan="2" rowspan="1">Hospitalized or non-hospitalized GI Bleeding</th>
                      </tr>
                      <tr>
                        <th align="center" rowspan="1" colspan="1">n/N</th>
                        <th align="center" rowspan="1" colspan="1">Rate (%)</th>
                        <th align="center" rowspan="1" colspan="1">n/N</th>
                        <th align="center" rowspan="1" colspan="1">Rate (%)</th>
                        <th align="center" rowspan="1" colspan="1">n/N</th>
                        <th align="center" rowspan="1" colspan="1">Rate (%)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Total</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">914 / 16676</td>
                        <td align="center" rowspan="1" colspan="1">5.5</td>
                        <td align="center" rowspan="1" colspan="1">2012 / 16676</td>
                        <td align="center" rowspan="1" colspan="1">12.1</td>
                        <td align="center" rowspan="1" colspan="1">2335 / 16676</td>
                        <td align="center" rowspan="1" colspan="1">14.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Antihypertensive RZ Group</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">411 / 7659</td>
                        <td align="center" rowspan="1" colspan="1">5.4</td>
                        <td align="center" rowspan="1" colspan="1">920 / 7659</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">1069 / 7659</td>
                        <td align="center" rowspan="1" colspan="1">14.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">244 / 4537</td>
                        <td align="center" rowspan="1" colspan="1">5.4</td>
                        <td align="center" rowspan="1" colspan="1">544 / 4537</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">620 / 4537</td>
                        <td align="center" rowspan="1" colspan="1">13.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">259 / 4480</td>
                        <td align="center" rowspan="1" colspan="1">5.8</td>
                        <td align="center" rowspan="1" colspan="1">548 / 4480</td>
                        <td align="center" rowspan="1" colspan="1">12.2</td>
                        <td align="center" rowspan="1" colspan="1">646 / 4480</td>
                        <td align="center" rowspan="1" colspan="1">14.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age groups</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    55–64</td>
                        <td align="center" rowspan="1" colspan="1">74 / 1438</td>
                        <td align="center" rowspan="1" colspan="1">5.1</td>
                        <td align="center" rowspan="1" colspan="1">165 / 1438</td>
                        <td align="center" rowspan="1" colspan="1">11.5</td>
                        <td align="center" rowspan="1" colspan="1">192 / 1438</td>
                        <td align="center" rowspan="1" colspan="1">13.4</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    65–69</td>
                        <td align="center" rowspan="1" colspan="1">232 / 5776</td>
                        <td align="center" rowspan="1" colspan="1">4.0</td>
                        <td align="center" rowspan="1" colspan="1">650 / 5776</td>
                        <td align="center" rowspan="1" colspan="1">11.3</td>
                        <td align="center" rowspan="1" colspan="1">724 / 5776</td>
                        <td align="center" rowspan="1" colspan="1">12.5</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    70 and older</td>
                        <td align="center" rowspan="1" colspan="1">608 / 9462</td>
                        <td align="center" rowspan="1" colspan="1">6.4</td>
                        <td align="center" rowspan="1" colspan="1">1197 / 9462</td>
                        <td align="center" rowspan="1" colspan="1">12.7</td>
                        <td align="center" rowspan="1" colspan="1">1419 / 9462</td>
                        <td align="center" rowspan="1" colspan="1">15.0</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Gender</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Female</td>
                        <td align="center" rowspan="1" colspan="1">522 / 9453</td>
                        <td align="center" rowspan="1" colspan="1">5.5</td>
                        <td align="center" rowspan="1" colspan="1">1146 / 9453</td>
                        <td align="center" rowspan="1" colspan="1">12.1</td>
                        <td align="center" rowspan="1" colspan="1">1336 / 9453</td>
                        <td align="center" rowspan="1" colspan="1">14.1</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Male</td>
                        <td align="center" rowspan="1" colspan="1">392 / 7223</td>
                        <td align="center" rowspan="1" colspan="1">5.4</td>
                        <td align="center" rowspan="1" colspan="1">866 / 7223</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">999 / 7223</td>
                        <td align="center" rowspan="1" colspan="1">13.8</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Race/ethnicity</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Black</td>
                        <td align="center" rowspan="1" colspan="1">357 / 5869</td>
                        <td align="center" rowspan="1" colspan="1">6.1</td>
                        <td align="center" rowspan="1" colspan="1">755 / 5869</td>
                        <td align="center" rowspan="1" colspan="1">12.9</td>
                        <td align="center" rowspan="1" colspan="1">885 / 5869</td>
                        <td align="center" rowspan="1" colspan="1">15.1</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Non-Black</td>
                        <td align="center" rowspan="1" colspan="1">557 / 10807</td>
                        <td align="center" rowspan="1" colspan="1">5.2</td>
                        <td align="center" rowspan="1" colspan="1">1257 / 10807</td>
                        <td align="center" rowspan="1" colspan="1">11.6</td>
                        <td align="center" rowspan="1" colspan="1">1450 / 10807</td>
                        <td align="center" rowspan="1" colspan="1">13.4</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Hispanic ethnicity</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Hispanic</td>
                        <td align="center" rowspan="1" colspan="1">150 / 3624</td>
                        <td align="center" rowspan="1" colspan="1">4.1</td>
                        <td align="center" rowspan="1" colspan="1">451 / 3624</td>
                        <td align="center" rowspan="1" colspan="1">12.4</td>
                        <td align="center" rowspan="1" colspan="1">495 / 3624</td>
                        <td align="center" rowspan="1" colspan="1">13.7</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Non-Hispanic</td>
                        <td align="center" rowspan="1" colspan="1">757 / 12962</td>
                        <td align="center" rowspan="1" colspan="1">5.8</td>
                        <td align="center" rowspan="1" colspan="1">1551 / 12962</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">1824 / 12962</td>
                        <td align="center" rowspan="1" colspan="1">14.1</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Antihypertensive treatment</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Treated (prior to baseline)</td>
                        <td align="center" rowspan="1" colspan="1">847 / 15143</td>
                        <td align="center" rowspan="1" colspan="1">5.6</td>
                        <td align="center" rowspan="1" colspan="1">1842 / 15143</td>
                        <td align="center" rowspan="1" colspan="1">12.2</td>
                        <td align="center" rowspan="1" colspan="1">2147 / 15143</td>
                        <td align="center" rowspan="1" colspan="1">14.2</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Untreated</td>
                        <td align="center" rowspan="1" colspan="1">67 / 1532</td>
                        <td align="center" rowspan="1" colspan="1">4.4</td>
                        <td align="center" rowspan="1" colspan="1">170 / 1532</td>
                        <td align="center" rowspan="1" colspan="1">11.1</td>
                        <td align="center" rowspan="1" colspan="1">188 / 1532</td>
                        <td align="center" rowspan="1" colspan="1">12.3</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Aspirin use at baseline</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes aspirin used</td>
                        <td align="center" rowspan="1" colspan="1">314 / 5912</td>
                        <td align="center" rowspan="1" colspan="1">5.3</td>
                        <td align="center" rowspan="1" colspan="1">702 / 5912</td>
                        <td align="center" rowspan="1" colspan="1">11.9</td>
                        <td align="center" rowspan="1" colspan="1">820 / 5912</td>
                        <td align="center" rowspan="1" colspan="1">13.9</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No aspirin</td>
                        <td align="center" rowspan="1" colspan="1">590 / 10532</td>
                        <td align="center" rowspan="1" colspan="1">5.6</td>
                        <td align="center" rowspan="1" colspan="1">1290 / 10532</td>
                        <td align="center" rowspan="1" colspan="1">12.2</td>
                        <td align="center" rowspan="1" colspan="1">1491 / 10532</td>
                        <td align="center" rowspan="1" colspan="1">14.2</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Women taking estrogen</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes</td>
                        <td align="center" rowspan="1" colspan="1">52 / 1261</td>
                        <td align="center" rowspan="1" colspan="1">4.1</td>
                        <td align="center" rowspan="1" colspan="1">159 / 1261</td>
                        <td align="center" rowspan="1" colspan="1">12.6</td>
                        <td align="center" rowspan="1" colspan="1">175 / 1261</td>
                        <td align="center" rowspan="1" colspan="1">13.9</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No</td>
                        <td align="center" rowspan="1" colspan="1">459 / 8015</td>
                        <td align="center" rowspan="1" colspan="1">5.7</td>
                        <td align="center" rowspan="1" colspan="1">962 / 8015</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">1132 / 8015</td>
                        <td align="center" rowspan="1" colspan="1">14.1</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">HDL cholesterol &lt;35 mg/dl</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes</td>
                        <td align="center" rowspan="1" colspan="1">88 / 1731</td>
                        <td align="center" rowspan="1" colspan="1">5.1</td>
                        <td align="center" rowspan="1" colspan="1">223 / 1731</td>
                        <td align="center" rowspan="1" colspan="1">12.9</td>
                        <td align="center" rowspan="1" colspan="1">254 / 1731</td>
                        <td align="center" rowspan="1" colspan="1">14.7</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No</td>
                        <td align="center" rowspan="1" colspan="1">826 / 14945</td>
                        <td align="center" rowspan="1" colspan="1">5.5</td>
                        <td align="center" rowspan="1" colspan="1">1789 / 14945</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">2081 / 14945</td>
                        <td align="center" rowspan="1" colspan="1">13.9</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Diabetes classification</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Diabetic</td>
                        <td align="center" rowspan="1" colspan="1">428 / 6660</td>
                        <td align="center" rowspan="1" colspan="1">6.4</td>
                        <td align="center" rowspan="1" colspan="1">842 / 6660</td>
                        <td align="center" rowspan="1" colspan="1">12.6</td>
                        <td align="center" rowspan="1" colspan="1">992 / 6660</td>
                        <td align="center" rowspan="1" colspan="1">14.9</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Non-diabetic</td>
                        <td align="center" rowspan="1" colspan="1">409 / 8718</td>
                        <td align="center" rowspan="1" colspan="1">4.7</td>
                        <td align="center" rowspan="1" colspan="1">1023 / 8718</td>
                        <td align="center" rowspan="1" colspan="1">11.7</td>
                        <td align="center" rowspan="1" colspan="1">1166 / 8718</td>
                        <td align="center" rowspan="1" colspan="1">13.4</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Cigarette smoking</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Smoker (current)</td>
                        <td align="center" rowspan="1" colspan="1">162 / 2777</td>
                        <td align="center" rowspan="1" colspan="1">5.8</td>
                        <td align="center" rowspan="1" colspan="1">300 / 2777</td>
                        <td align="center" rowspan="1" colspan="1">10.8</td>
                        <td align="center" rowspan="1" colspan="1">357 / 2777</td>
                        <td align="center" rowspan="1" colspan="1">12.9</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Nonsmoker (non/former)</td>
                        <td align="center" rowspan="1" colspan="1">752 / 13898</td>
                        <td align="center" rowspan="1" colspan="1">5.4</td>
                        <td align="center" rowspan="1" colspan="1">1712 / 13898</td>
                        <td align="center" rowspan="1" colspan="1">12.3</td>
                        <td align="center" rowspan="1" colspan="1">1978 / 13898</td>
                        <td align="center" rowspan="1" colspan="1">14.2</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">History of CHD</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes</td>
                        <td align="center" rowspan="1" colspan="1">254 / 4493</td>
                        <td align="center" rowspan="1" colspan="1">5.7</td>
                        <td align="center" rowspan="1" colspan="1">548 / 4493</td>
                        <td align="center" rowspan="1" colspan="1">12.2</td>
                        <td align="center" rowspan="1" colspan="1">640 / 4493</td>
                        <td align="center" rowspan="1" colspan="1">14.2</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No</td>
                        <td align="center" rowspan="1" colspan="1">649 / 12075</td>
                        <td align="center" rowspan="1" colspan="1">5.4</td>
                        <td align="center" rowspan="1" colspan="1">1447 / 12075</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">1672 / 12075</td>
                        <td align="center" rowspan="1" colspan="1">13.8</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Atherosclerotic CVD</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes</td>
                        <td align="center" rowspan="1" colspan="1">546 / 9376</td>
                        <td align="center" rowspan="1" colspan="1">5.8</td>
                        <td align="center" rowspan="1" colspan="1">1166 / 9376</td>
                        <td align="center" rowspan="1" colspan="1">12.4</td>
                        <td align="center" rowspan="1" colspan="1">1362 / 9376</td>
                        <td align="center" rowspan="1" colspan="1">14.5</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No</td>
                        <td align="center" rowspan="1" colspan="1">368 / 7300</td>
                        <td align="center" rowspan="1" colspan="1">5.0</td>
                        <td align="center" rowspan="1" colspan="1">846 / 7300</td>
                        <td align="center" rowspan="1" colspan="1">11.6</td>
                        <td align="center" rowspan="1" colspan="1">973 / 7300</td>
                        <td align="center" rowspan="1" colspan="1">13.3</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    History MI or stroke</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes</td>
                        <td align="center" rowspan="1" colspan="1">273 / 4136</td>
                        <td align="center" rowspan="1" colspan="1">6.6</td>
                        <td align="center" rowspan="1" colspan="1">512 / 4136</td>
                        <td align="center" rowspan="1" colspan="1">12.4</td>
                        <td align="center" rowspan="1" colspan="1">618 / 4136</td>
                        <td align="center" rowspan="1" colspan="1">14.9</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No</td>
                        <td align="center" rowspan="1" colspan="1">641 / 12540</td>
                        <td align="center" rowspan="1" colspan="1">5.1</td>
                        <td align="center" rowspan="1" colspan="1">1500 / 12540</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">1717 / 12540</td>
                        <td align="center" rowspan="1" colspan="1">13.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">History of coronary revascularization</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes</td>
                        <td align="center" rowspan="1" colspan="1">133 / 2315</td>
                        <td align="center" rowspan="1" colspan="1">5.7</td>
                        <td align="center" rowspan="1" colspan="1">292 / 2315</td>
                        <td align="center" rowspan="1" colspan="1">12.6</td>
                        <td align="center" rowspan="1" colspan="1">337 / 2315</td>
                        <td align="center" rowspan="1" colspan="1">14.6</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No</td>
                        <td align="center" rowspan="1" colspan="1">781 / 14361</td>
                        <td align="center" rowspan="1" colspan="1">5.4</td>
                        <td align="center" rowspan="1" colspan="1">1720 / 14361</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">1998 / 14361</td>
                        <td align="center" rowspan="1" colspan="1">13.9</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Other atherosclerotic CVD</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes</td>
                        <td align="center" rowspan="1" colspan="1">256 / 4550</td>
                        <td align="center" rowspan="1" colspan="1">5.6</td>
                        <td align="center" rowspan="1" colspan="1">576 / 4550</td>
                        <td align="center" rowspan="1" colspan="1">12.7</td>
                        <td align="center" rowspan="1" colspan="1">670 / 4550</td>
                        <td align="center" rowspan="1" colspan="1">14.7</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No</td>
                        <td align="center" rowspan="1" colspan="1">658 / 12126</td>
                        <td align="center" rowspan="1" colspan="1">5.4</td>
                        <td align="center" rowspan="1" colspan="1">1436 / 12126</td>
                        <td align="center" rowspan="1" colspan="1">11.8</td>
                        <td align="center" rowspan="1" colspan="1">1665 / 12126</td>
                        <td align="center" rowspan="1" colspan="1">13.7</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Major ST segment depression</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes</td>
                        <td align="center" rowspan="1" colspan="1">98 / 1745</td>
                        <td align="center" rowspan="1" colspan="1">5.6</td>
                        <td align="center" rowspan="1" colspan="1">208 / 1745</td>
                        <td align="center" rowspan="1" colspan="1">11.9</td>
                        <td align="center" rowspan="1" colspan="1">236 / 1745</td>
                        <td align="center" rowspan="1" colspan="1">13.5</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No</td>
                        <td align="center" rowspan="1" colspan="1">806 / 14800</td>
                        <td align="center" rowspan="1" colspan="1">5.4</td>
                        <td align="center" rowspan="1" colspan="1">1784 / 14800</td>
                        <td align="center" rowspan="1" colspan="1">12.1</td>
                        <td align="center" rowspan="1" colspan="1">2074 / 14800</td>
                        <td align="center" rowspan="1" colspan="1">14.0</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">LVH by Minnesota Code</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Hard LVH</td>
                        <td align="center" rowspan="1" colspan="1">59 / 775</td>
                        <td align="center" rowspan="1" colspan="1">7.6</td>
                        <td align="center" rowspan="1" colspan="1">83 / 775</td>
                        <td align="center" rowspan="1" colspan="1">10.7</td>
                        <td align="center" rowspan="1" colspan="1">108 / 775</td>
                        <td align="center" rowspan="1" colspan="1">13.9</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No LVH</td>
                        <td align="center" rowspan="1" colspan="1">701 / 13239</td>
                        <td align="center" rowspan="1" colspan="1">5.3</td>
                        <td align="center" rowspan="1" colspan="1">1580 / 13239</td>
                        <td align="center" rowspan="1" colspan="1">11.9</td>
                        <td align="center" rowspan="1" colspan="1">1830 / 13239</td>
                        <td align="center" rowspan="1" colspan="1">13.8</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Lipid trial participants</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Yes</td>
                        <td align="center" rowspan="1" colspan="1">179 / 3951</td>
                        <td align="center" rowspan="1" colspan="1">4.5</td>
                        <td align="center" rowspan="1" colspan="1">479 / 3951</td>
                        <td align="center" rowspan="1" colspan="1">12.1</td>
                        <td align="center" rowspan="1" colspan="1">537 / 3951</td>
                        <td align="center" rowspan="1" colspan="1">13.6</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    No</td>
                        <td align="center" rowspan="1" colspan="1">735 / 12725</td>
                        <td align="center" rowspan="1" colspan="1">5.8</td>
                        <td align="center" rowspan="1" colspan="1">1533 / 12725</td>
                        <td align="center" rowspan="1" colspan="1">12.0</td>
                        <td align="center" rowspan="1" colspan="1">1798 / 12725</td>
                        <td align="center" rowspan="1" colspan="1">14.1</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
              </table-wrap>
              <table-wrap position="float" id="pone.0260107.t003">
                <object-id pub-id-type="doi">10.1371/journal.pone.0260107.t003</object-id>
                <label>Table 3</label>
                <caption>
                  <title>Hazard ratios (95% CI) for GI bleeding within subgroup by 3 RCT arms comparison.</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0260107.t003" id="pone.0260107.t003g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="justify" rowspan="1" colspan="1"/>
                        <th align="center" colspan="2" rowspan="1">Hospitalized GI Bleeding</th>
                        <th align="center" colspan="2" rowspan="1">Non-hospitalized GI Bleeding</th>
                        <th align="center" colspan="2" rowspan="1">Hospitalized or non-hospitalized GI Bleeding</th>
                      </tr>
                      <tr>
                        <th align="justify" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="center" rowspan="1" colspan="1">
                          <italic toggle="yes">P value</italic>
                        </th>
                        <th align="center" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="center" rowspan="1" colspan="1">
                          <italic toggle="yes">P value</italic>
                        </th>
                        <th align="center" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="center" rowspan="1" colspan="1">
                          <italic toggle="yes">P value</italic>
                        </th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Follow-up by 3/31/2002 events/total</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">0.98 (0.83–1.15)</td>
                        <td align="center" rowspan="1" colspan="1">0.78</td>
                        <td align="center" rowspan="1" colspan="1">1.07 (0.96–1.19)</td>
                        <td align="center" rowspan="1" colspan="1">0.21</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.95–1.16)</td>
                        <td align="center" rowspan="1" colspan="1">0.35</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">0.98 (0.82–1.16)</td>
                        <td align="center" rowspan="1" colspan="1">0.79</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.90–1.14)</td>
                        <td align="center" rowspan="1" colspan="1">0.88</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.91–1.13)</td>
                        <td align="center" rowspan="1" colspan="1">0.81</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.85–1.16)</td>
                        <td align="center" rowspan="1" colspan="1">0.95</td>
                        <td align="center" rowspan="1" colspan="1">0.95 (0.85–1.05)</td>
                        <td align="center" rowspan="1" colspan="1">0.30</td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.88–1.07)</td>
                        <td align="center" rowspan="1" colspan="1">0.53</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">
                          <bold>Stratified by subgroups:</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">In Black patients</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">0.93 (0.72–1.20)</td>
                        <td align="center" rowspan="1" colspan="1">0.58 (0.49)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">0.98 (0.83–1.17)</td>
                        <td align="center" rowspan="1" colspan="1">0.86 (0.81)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.82–1.13)</td>
                        <td align="center" rowspan="1" colspan="1">0.67 (0.37)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.10 (0.83–1.45)</td>
                        <td align="center" rowspan="1" colspan="1">0.50 (0.90)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.80–1.18)</td>
                        <td align="center" rowspan="1" colspan="1">0.76 (0.49)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.02 (0.86–1.22)</td>
                        <td align="center" rowspan="1" colspan="1">0.80 (0.57)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.18 (0.92–1.51)</td>
                        <td align="center" rowspan="1" colspan="1">0.20 (0.40)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">0.98 (0.83–1.17)</td>
                        <td align="center" rowspan="1" colspan="1">0.85 (0.59)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.06 (0.90–1.24)</td>
                        <td align="center" rowspan="1" colspan="1">0.50 (0.79)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">In non-Black patients</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.85–1.28)</td>
                        <td align="center" rowspan="1" colspan="1">0.67</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.88–1.16)</td>
                        <td align="center" rowspan="1" colspan="1">0.86</td>
                        <td align="center" rowspan="1" colspan="1">1.06 (0.93–1.20)</td>
                        <td align="center" rowspan="1" colspan="1">0.36</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.07 (0.86–1.35)</td>
                        <td align="center" rowspan="1" colspan="1">0.53</td>
                        <td align="center" rowspan="1" colspan="1">1.06 (0.91–1.23)</td>
                        <td align="center" rowspan="1" colspan="1">0.47</td>
                        <td align="center" rowspan="1" colspan="1">1.09 (0.95–1.26)</td>
                        <td align="center" rowspan="1" colspan="1">0.22</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.03 (0.84–1.25)</td>
                        <td align="center" rowspan="1" colspan="1">0.79</td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.91–1.19)</td>
                        <td align="center" rowspan="1" colspan="1">0.53</td>
                        <td align="center" rowspan="1" colspan="1">1.03 (0.91–1.16)</td>
                        <td align="center" rowspan="1" colspan="1">0.66</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Women</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.08 (0.88–1.34)</td>
                        <td align="center" rowspan="1" colspan="1">0.47</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.87–1.15)</td>
                        <td align="center" rowspan="1" colspan="1">0.97</td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.91–1.18)</td>
                        <td align="center" rowspan="1" colspan="1">0.58</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.15 (0.91–1.45)</td>
                        <td align="center" rowspan="1" colspan="1">0.25</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.86–1.18)</td>
                        <td align="center" rowspan="1" colspan="1">0.91</td>
                        <td align="center" rowspan="1" colspan="1">1.07 (0.92–1.24)</td>
                        <td align="center" rowspan="1" colspan="1">0.36</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.06 (0.86–1.30)</td>
                        <td align="center" rowspan="1" colspan="1">0.57</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.88–1.17)</td>
                        <td align="center" rowspan="1" colspan="1">0.87</td>
                        <td align="center" rowspan="1" colspan="1">1.03 (0.91–1.17)</td>
                        <td align="center" rowspan="1" colspan="1">0.64</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Men</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">0.90 (0.71–1.15)</td>
                        <td align="center" rowspan="1" colspan="1">0.39 (0.26)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.86–1.19)</td>
                        <td align="center" rowspan="1" colspan="1">0.92 (0.92)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.86–1.17)</td>
                        <td align="center" rowspan="1" colspan="1">0.94 (0.76)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.77–1.30)</td>
                        <td align="center" rowspan="1" colspan="1">0.98 (0.46)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.87–1.25)</td>
                        <td align="center" rowspan="1" colspan="1">0.66 (0.79)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.89–1.25)</td>
                        <td align="center" rowspan="1" colspan="1">0.53 (0.90)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.11 (0.88–1.42)</td>
                        <td align="center" rowspan="1" colspan="1">0.37 (0.76)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.03 (0.88–1.21)</td>
                        <td align="center" rowspan="1" colspan="1">0.70 (0.85)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.90–1.22)</td>
                        <td align="center" rowspan="1" colspan="1">0.53 (0.86)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Aspirin use at baseline</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.79–1.38)</td>
                        <td align="center" rowspan="1" colspan="1">0.75 (0.64)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.82–1.19)</td>
                        <td align="center" rowspan="1" colspan="1">0.92 (0.87)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.06 (0.89–1.25)</td>
                        <td align="center" rowspan="1" colspan="1">0.53 (0.65)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.20 (0.89–1.62)</td>
                        <td align="center" rowspan="1" colspan="1">0.23 (0.37)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.18 (0.97–1.44)</td>
                        <td align="center" rowspan="1" colspan="1">0.10 (0.09)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.23 (1.02–1.48)</td>
                        <td align="center" rowspan="1" colspan="1">0.03 (0.06)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.15 (0.88–1.49)</td>
                        <td align="center" rowspan="1" colspan="1">0.30 (0.61)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.19 (1.00–1.42)</td>
                        <td align="center" rowspan="1" colspan="1">0.05 (0.04)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.16 (0.99–1.36)</td>
                        <td align="center" rowspan="1" colspan="1">0.07 (0.10)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">No-Aspirin use at baseline</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.79–1.17)</td>
                        <td align="center" rowspan="1" colspan="1">0.72</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.89–1.15)</td>
                        <td align="center" rowspan="1" colspan="1">0.89</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.89–1.14)</td>
                        <td align="center" rowspan="1" colspan="1">0.91</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.02 (0.82–1.26)</td>
                        <td align="center" rowspan="1" colspan="1">0.89</td>
                        <td align="center" rowspan="1" colspan="1">0.95 (0.82–1.11)</td>
                        <td align="center" rowspan="1" colspan="1">0.55</td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.86–1.13)</td>
                        <td align="center" rowspan="1" colspan="1">0.86</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.86–1.28)</td>
                        <td align="center" rowspan="1" colspan="1">0.61</td>
                        <td align="center" rowspan="1" colspan="1">0.94 (0.83–1.08)</td>
                        <td align="center" rowspan="1" colspan="1">0.40</td>
                        <td align="center" rowspan="1" colspan="1">0.98 (0.86–1.11)</td>
                        <td align="center" rowspan="1" colspan="1">0.73</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Age 55–64 yrs</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.36 (0.77–2.42)</td>
                        <td align="center" rowspan="1" colspan="1">0.29 (0.53)<xref rid="t003fn002" ref-type="table-fn">**</xref></td>
                        <td align="center" rowspan="1" colspan="1">0.84 (0.58–1.21)</td>
                        <td align="center" rowspan="1" colspan="1">0.35 (0.35)<xref rid="t003fn002" ref-type="table-fn">**</xref></td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.70–1.39)</td>
                        <td align="center" rowspan="1" colspan="1">0.94 (0.61)<xref rid="t003fn002" ref-type="table-fn">**</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.31 (0.69–2.50)</td>
                        <td align="center" rowspan="1" colspan="1">0.42 (0.83)<xref rid="t003fn002" ref-type="table-fn">**</xref></td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.66–1.49)</td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.95)<xref rid="t003fn002" ref-type="table-fn">**</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.71–1.53)</td>
                        <td align="center" rowspan="1" colspan="1">0.83 (0.90)<xref rid="t003fn002" ref-type="table-fn">**</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">0.95 (0.55–1.65)</td>
                        <td align="center" rowspan="1" colspan="1">0.87 (0.90)<xref rid="t003fn002" ref-type="table-fn">**</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.17 (0.80–1.70)</td>
                        <td align="center" rowspan="1" colspan="1">0.41 (0.55)<xref rid="t003fn002" ref-type="table-fn">**</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.74–1.48)</td>
                        <td align="center" rowspan="1" colspan="1">0.78 (0.88)<xref rid="t003fn002" ref-type="table-fn">**</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Age 65–69 yrs</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">0.95 (0.69–1.29)</td>
                        <td align="center" rowspan="1" colspan="1">0.73</td>
                        <td align="center" rowspan="1" colspan="1">1.11 (0.92–1.34)</td>
                        <td align="center" rowspan="1" colspan="1">0.29</td>
                        <td align="center" rowspan="1" colspan="1">1.10 (0.92–1.32)</td>
                        <td align="center" rowspan="1" colspan="1">0.28</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.75–1.48)</td>
                        <td align="center" rowspan="1" colspan="1">0.78</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.85–1.30)</td>
                        <td align="center" rowspan="1" colspan="1">0.63</td>
                        <td align="center" rowspan="1" colspan="1">1.11 (0.91–1.35)</td>
                        <td align="center" rowspan="1" colspan="1">0.32</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.11 (0.82–1.52)</td>
                        <td align="center" rowspan="1" colspan="1">0.50</td>
                        <td align="center" rowspan="1" colspan="1">0.95 (0.79–1.14)</td>
                        <td align="center" rowspan="1" colspan="1">0.59</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.84–1.19)</td>
                        <td align="center" rowspan="1" colspan="1">0.99</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Age 70 yrs or older</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">0.98 (0.81–1.19)</td>
                        <td align="center" rowspan="1" colspan="1">0.87</td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.85–1.11)</td>
                        <td align="center" rowspan="1" colspan="1">0.68</td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.87–1.12)</td>
                        <td align="center" rowspan="1" colspan="1">0.86</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.07 (0.86–1.32)</td>
                        <td align="center" rowspan="1" colspan="1">0.55</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.87–1.18)</td>
                        <td align="center" rowspan="1" colspan="1">0.86</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.91–1.20)</td>
                        <td align="center" rowspan="1" colspan="1">0.54</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.09 (0.90–1.31)</td>
                        <td align="center" rowspan="1" colspan="1">0.40</td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.91–1.20)</td>
                        <td align="center" rowspan="1" colspan="1">0.54</td>
                        <td align="center" rowspan="1" colspan="1">1.06 (0.93–1.20)</td>
                        <td align="center" rowspan="1" colspan="1">0.39</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Non-smokers (ever/never)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.84–1.19)</td>
                        <td align="center" rowspan="1" colspan="1">0.96</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.89–1.12)</td>
                        <td align="center" rowspan="1" colspan="1">0.97</td>
                        <td align="center" rowspan="1" colspan="1">1.02 (0.92–1.14)</td>
                        <td align="center" rowspan="1" colspan="1">0.72</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.07 (0.88–1.30)</td>
                        <td align="center" rowspan="1" colspan="1">0.48</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.88–1.14)</td>
                        <td align="center" rowspan="1" colspan="1">0.93</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.93–1.19)</td>
                        <td align="center" rowspan="1" colspan="1">0.40</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.08 (0.91–1.28)</td>
                        <td align="center" rowspan="1" colspan="1">0.39</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.89–1.13)</td>
                        <td align="center" rowspan="1" colspan="1">0.96</td>
                        <td align="center" rowspan="1" colspan="1">1.03 (0.93–1.15)</td>
                        <td align="center" rowspan="1" colspan="1">0.56</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Smokers (current)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.02 (0.70–1.49)</td>
                        <td align="center" rowspan="1" colspan="1">0.91 (0.90)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.76–1.32)</td>
                        <td align="center" rowspan="1" colspan="1">0.98 (0.97)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.81–1.34)</td>
                        <td align="center" rowspan="1" colspan="1">0.75 (0.88)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">1.13 (0.75–1.71)</td>
                        <td align="center" rowspan="1" colspan="1">0.56 (0.82)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.12 (0.83–1.53)</td>
                        <td align="center" rowspan="1" colspan="1">0.45 (0.51)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.13 (0.85–1.49)</td>
                        <td align="center" rowspan="1" colspan="1">0.41 (0.67)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.11 (0.76–1.60)</td>
                        <td align="center" rowspan="1" colspan="1">0.59 (0.90)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.13 (0.86–1.48)</td>
                        <td align="center" rowspan="1" colspan="1">0.37 (0.43)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">1.08 (0.84–1.39)</td>
                        <td align="center" rowspan="1" colspan="1">0.54 (0.74)<xref rid="t003fn001" ref-type="table-fn">*</xref></td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t003fn001">
                    <p>* P value for interaction</p>
                  </fn>
                  <fn id="t003fn002">
                    <p>**Likelihood ratio test P value for interaction.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p><xref rid="pone.0260107.t002" ref-type="table">Table 2</xref> also presents the cumulative incidence of GI bleeding by age, gender, race/ethnicity, previous use of antihypertensives, use of aspirin and estrogen, HDL cholesterol level, smoking status, and history of comorbid conditions (diabetes, CHD, CVD, MI, stroke, or CABG). For example, the cumulative incidence of hospitalized GI bleeding was higher in patients aged 70 or older (6.4%) than those 55–64 (5.1%) or 65–69 (4.0%). The cumulative incidences of GI bleeding were similar by other factors in <xref rid="pone.0260107.t002" ref-type="table">Table 2</xref>.</p>
              <p>Furthermore, <xref rid="pone.0260107.t003" ref-type="table">Table 3</xref> presents the results of interaction between trial drugs and those factors (age, gender, race, aspirin use, and smoking status) on the risk of GI bleeding, but did not find any of these interactions significant. <xref rid="pone.0260107.t004" ref-type="table">Table 4</xref> classified the cumulative incidence at 3 different time intervals: at 1 year, 3 year and 5 year for overall population and also for the stratified results by age, sex, race, use of aspirin and estrogen, and smoking status. Although the cumulative incidence rates of GI bleeding increased substantially at 5 years as compared to those at 1 year, the cumulative incidence rates of GI bleeding were generally similar among the 3 trial arms (lisinopril, amlodipine, and chlorthalidone). However, in those with prior aspirin use and smoking group, patients with lisinopril had slightly higher incidence of GI bleeding (13.3% and 12.5% respectively) than those with amlodipine (10.2% and 9.8% respectively).</p>
              <table-wrap position="float" id="pone.0260107.t004">
                <object-id pub-id-type="doi">10.1371/journal.pone.0260107.t004</object-id>
                <label>Table 4</label>
                <caption>
                  <title>Cumulative proportion of participants with GI bleeding by year, subgroup, and RCT arms.</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0260107.t004" id="pone.0260107.t004g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="justify" rowspan="1" colspan="1"/>
                        <th align="center" colspan="6" rowspan="1">Cumulative Incidence % (95% CI) of GI Bleeding per 1000 participants at the End of the Specified Year</th>
                      </tr>
                      <tr>
                        <th align="justify" rowspan="1" colspan="1"/>
                        <th align="center" colspan="3" rowspan="1">Hospitalized GI Bleeding</th>
                        <th align="center" colspan="3" rowspan="1">Hospitalized and Non-hospitalized GI Bleeding</th>
                      </tr>
                      <tr>
                        <th align="justify" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">Year 1</th>
                        <th align="center" rowspan="1" colspan="1">Year 3</th>
                        <th align="center" rowspan="1" colspan="1">Year 5</th>
                        <th align="center" rowspan="1" colspan="1">Year 1</th>
                        <th align="center" rowspan="1" colspan="1">Year 3</th>
                        <th align="center" rowspan="1" colspan="1">Year 5</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1">Total</td>
                        <td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1"/>
                        <td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1"/>
                        <td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1"/>
                        <td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1"/>
                        <td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1"/>
                        <td align="justify" style="background-color:#D9D9D9" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">6.4 (4.8–8.5)</td>
                        <td align="center" rowspan="1" colspan="1">24.8 (21.6–28.5)</td>
                        <td align="center" rowspan="1" colspan="1">47.0 (42.4–52.1)</td>
                        <td align="center" rowspan="1" colspan="1">6.5 (5.0–8.6)</td>
                        <td align="center" rowspan="1" colspan="1">50.4 (45.7–55.5)</td>
                        <td align="center" rowspan="1" colspan="1">118.0 (110.8–125.7)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">7.1 (5.0–10.0)</td>
                        <td align="center" rowspan="1" colspan="1">24.7 (20.6–29.6)</td>
                        <td align="center" rowspan="1" colspan="1">46.9 (41.0–53.6)</td>
                        <td align="center" rowspan="1" colspan="1">7.5 (5.4–10.5)</td>
                        <td align="center" rowspan="1" colspan="1">48.5 (42.6–55.1)</td>
                        <td align="center" rowspan="1" colspan="1">111.3 (102.3–121.1)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">9.4 (6.9–12.7)</td>
                        <td align="center" rowspan="1" colspan="1">27.7 (23.3–32.9)</td>
                        <td align="center" rowspan="1" colspan="1">50.0 (43.8–56.9)</td>
                        <td align="center" rowspan="1" colspan="1">10.0 (7.5–13.4)</td>
                        <td align="center" rowspan="1" colspan="1">51.6 (45.5–58.4)</td>
                        <td align="center" rowspan="1" colspan="1">120.1 (110.7–130.3)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Black</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">6.7 (4.2–10.6)</td>
                        <td align="center" rowspan="1" colspan="1">25.2 (20.0–31.9)</td>
                        <td align="center" rowspan="1" colspan="1">50.1 (42.3–59.2)</td>
                        <td align="center" rowspan="1" colspan="1">6.7 (4.2–10.6)</td>
                        <td align="center" rowspan="1" colspan="1">46.8 (39.4–55.4)</td>
                        <td align="center" rowspan="1" colspan="1">121.4 (109.4–134.7)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">5.0 (2.5–9.9)</td>
                        <td align="center" rowspan="1" colspan="1">30.3 (23.0–39.9)</td>
                        <td align="center" rowspan="1" colspan="1">52.0 (42.1–64.3)</td>
                        <td align="center" rowspan="1" colspan="1">5.0 (2.5–9.9)</td>
                        <td align="center" rowspan="1" colspan="1">58.8 (48.4–71.4)</td>
                        <td align="center" rowspan="1" colspan="1">121.3 (106.1–138.6)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">9.6 (5.8–15.9)</td>
                        <td align="center" rowspan="1" colspan="1">30.8 (23.3–40.6)</td>
                        <td align="center" rowspan="1" colspan="1">53.8 (43.6–66.4)</td>
                        <td align="center" rowspan="1" colspan="1">9.6 (5.8–15.9)</td>
                        <td align="center" rowspan="1" colspan="1">50.6 (40.8–62.7)</td>
                        <td align="center" rowspan="1" colspan="1">124.6 (108.8–142.5)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Non-black</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">6.2 (4.4–8.9)</td>
                        <td align="center" rowspan="1" colspan="1">24.6 (20.6–29.3)</td>
                        <td align="center" rowspan="1" colspan="1">45.4 (39.7–51.8)</td>
                        <td align="center" rowspan="1" colspan="1">6.4 (4.6–9.1)</td>
                        <td align="center" rowspan="1" colspan="1">52.4 (46.5–58.9)</td>
                        <td align="center" rowspan="1" colspan="1">116.1 (107.3–125.7)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">8.2 (5.5–12.2)</td>
                        <td align="center" rowspan="1" colspan="1">21.6 (16.9–27.5)</td>
                        <td align="center" rowspan="1" colspan="1">44.1 (37.1–52.5)</td>
                        <td align="center" rowspan="1" colspan="1">8.9 (6.1–13.0)</td>
                        <td align="center" rowspan="1" colspan="1">42.8 (36.0–50.8)</td>
                        <td align="center" rowspan="1" colspan="1">105.8 (94.8–117.9)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">9.2 (6.4–13.5)</td>
                        <td align="center" rowspan="1" colspan="1">26.0 (20.8–32.5)</td>
                        <td align="center" rowspan="1" colspan="1">47.9 (40.6–56.6)</td>
                        <td align="center" rowspan="1" colspan="1">10.3 (7.2–14.7)</td>
                        <td align="center" rowspan="1" colspan="1">52.1 (44.6–60.7)</td>
                        <td align="center" rowspan="1" colspan="1">117.7 (106.2–130.3)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Women</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">7.3 (5.2–10.3)</td>
                        <td align="center" rowspan="1" colspan="1">25.1 (20.9–30.2)</td>
                        <td align="center" rowspan="1" colspan="1">48.5 (42.4–55.6)</td>
                        <td align="center" rowspan="1" colspan="1">7.5 (5.4–10.6)</td>
                        <td align="center" rowspan="1" colspan="1">49.7 (43.7–56.6)</td>
                        <td align="center" rowspan="1" colspan="1">117.6 (108.1–127.8)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">8.5 (5.6–12.9)</td>
                        <td align="center" rowspan="1" colspan="1">22.9 (17.8–29.4)</td>
                        <td align="center" rowspan="1" colspan="1">44.1 (36.7–53.1)</td>
                        <td align="center" rowspan="1" colspan="1">8.9 (5.9–13.4)</td>
                        <td align="center" rowspan="1" colspan="1">46.9 (39.4–55.8)</td>
                        <td align="center" rowspan="1" colspan="1">111.4 (99.5–124.5)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">9.6 (6.5–14.4)</td>
                        <td align="center" rowspan="1" colspan="1">27.7 (22.0–35.0)</td>
                        <td align="center" rowspan="1" colspan="1">50.9 (42.7–60.6)</td>
                        <td align="center" rowspan="1" colspan="1">10.4 (7.1–15.3)</td>
                        <td align="center" rowspan="1" colspan="1">49.8 (41.9–59.1)</td>
                        <td align="center" rowspan="1" colspan="1">121.1 (108.5–135.1)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Men</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">5.2 (3.2–8.3)</td>
                        <td align="center" rowspan="1" colspan="1">24.4 (19.7–30.3)</td>
                        <td align="center" rowspan="1" colspan="1">44.9 (38.2–52.8)</td>
                        <td align="center" rowspan="1" colspan="1">5.2 (3.2–8.3)</td>
                        <td align="center" rowspan="1" colspan="1">51.3 (44.2–59.4)</td>
                        <td align="center" rowspan="1" colspan="1">118.6 (107.7–130.5)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">5.1 (2.8–9.5)</td>
                        <td align="center" rowspan="1" colspan="1">27.1 (20.8–35.3)</td>
                        <td align="center" rowspan="1" colspan="1">50.6 (41.6–61.5)</td>
                        <td align="center" rowspan="1" colspan="1">5.6 (3.1–10.1)</td>
                        <td align="center" rowspan="1" colspan="1">50.6 (41.8–61.3)</td>
                        <td align="center" rowspan="1" colspan="1">111.2 (97.8–126.4)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">9.0 (5.7–14.3)</td>
                        <td align="center" rowspan="1" colspan="1">27.6 (21.3–35.8)</td>
                        <td align="center" rowspan="1" colspan="1">48.8 (40.1–59.4)</td>
                        <td align="center" rowspan="1" colspan="1">9.5 (6.1–14.9)</td>
                        <td align="center" rowspan="1" colspan="1">53.7 (44.7–64.6)</td>
                        <td align="center" rowspan="1" colspan="1">119.0 (105.3–134.4)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Aspirin use</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">8.2 (5.4–12.4)</td>
                        <td align="center" rowspan="1" colspan="1">25.6 (20.3–32.3)</td>
                        <td align="center" rowspan="1" colspan="1">44.9 (37.5–53.7)</td>
                        <td align="center" rowspan="1" colspan="1">8.5 (5.7–12.8)</td>
                        <td align="center" rowspan="1" colspan="1">51.2 (43.5–60.2)</td>
                        <td align="center" rowspan="1" colspan="1">112.9 (101.2–125.9)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">5.6 (2.9–10.8)</td>
                        <td align="center" rowspan="1" colspan="1">20.1 (14.2–28.3)</td>
                        <td align="center" rowspan="1" colspan="1">43.2 (34.1–54.7)</td>
                        <td align="center" rowspan="1" colspan="1">5.6 (2.9–10.8)</td>
                        <td align="center" rowspan="1" colspan="1">39.5 (31.0–50.3)</td>
                        <td align="center" rowspan="1" colspan="1">102.3 (88.1–118.6)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">8.0 (4.7–13.7)</td>
                        <td align="center" rowspan="1" colspan="1">29.6 (22.4–39.0)</td>
                        <td align="center" rowspan="1" colspan="1">48.6 (39.0–60.4)</td>
                        <td align="center" rowspan="1" colspan="1">8.6 (5.1–14.5)</td>
                        <td align="center" rowspan="1" colspan="1">56.7 (46.4–69.0)</td>
                        <td align="center" rowspan="1" colspan="1">132.9 (117.0–150.8)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">No Aspirin use</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">4.9 (3.3–7.4)</td>
                        <td align="center" rowspan="1" colspan="1">24.1 (20.2–28.9)</td>
                        <td align="center" rowspan="1" colspan="1">48.0 (42.2–54.6)</td>
                        <td align="center" rowspan="1" colspan="1">4.9 (3.3–7.4)</td>
                        <td align="center" rowspan="1" colspan="1">49.5 (43.7–56.0)</td>
                        <td align="center" rowspan="1" colspan="1">120.9 (111.8–130.7)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">8.0 (5.3–12.0)</td>
                        <td align="center" rowspan="1" colspan="1">27.4 (22.0–34.0)</td>
                        <td align="center" rowspan="1" colspan="1">49.5 (42.0–58.2)</td>
                        <td align="center" rowspan="1" colspan="1">8.7 (5.9–12.8)</td>
                        <td align="center" rowspan="1" colspan="1">53.0 (45.4–61.8)</td>
                        <td align="center" rowspan="1" colspan="1">116.2 (104.7–128.8)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">10.4 (7.2–14.9)</td>
                        <td align="center" rowspan="1" colspan="1">26.5 (21.1–33.1)</td>
                        <td align="center" rowspan="1" colspan="1">50.8 (43.1–59.9)</td>
                        <td align="center" rowspan="1" colspan="1">11.1 (7.8–15.7)</td>
                        <td align="center" rowspan="1" colspan="1">48.3 (41.0–56.9)</td>
                        <td align="center" rowspan="1" colspan="1">113.4 (101.8–126.2)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Age 55–64 yrs</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">7.6 (3.2–18.2)</td>
                        <td align="center" rowspan="1" colspan="1">32.0 (21.0–48.7)</td>
                        <td align="center" rowspan="1" colspan="1">54.2 (39.2–74.7)</td>
                        <td align="center" rowspan="1" colspan="1">7.6 (3.2–18.2)</td>
                        <td align="center" rowspan="1" colspan="1">48.8 (34.7–68.3)</td>
                        <td align="center" rowspan="1" colspan="1">116.9 (94.1–144.8)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">0.0 (*—*)</td>
                        <td align="center" rowspan="1" colspan="1">14.7 (6.6–32.4)</td>
                        <td align="center" rowspan="1" colspan="1">36.8 (22.3–60.2)</td>
                        <td align="center" rowspan="1" colspan="1">0.0 (*—*)</td>
                        <td align="center" rowspan="1" colspan="1">53.9 (35.8–80.7)</td>
                        <td align="center" rowspan="1" colspan="1">113.6 (85.6–150.2)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">5.3 (1.3–21.2)</td>
                        <td align="center" rowspan="1" colspan="1">16.0 (7.2–35.4)</td>
                        <td align="center" rowspan="1" colspan="1">45.3 (27.7–73.4)</td>
                        <td align="center" rowspan="1" colspan="1">8.0 (2.6–24.7)</td>
                        <td align="center" rowspan="1" colspan="1">45.5 (28.5–72.1)</td>
                        <td align="center" rowspan="1" colspan="1">129.3 (98.2–169.3)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Age 65–69 yrs</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">3.0 (1.5–6.0)</td>
                        <td align="center" rowspan="1" colspan="1">15.4 (11.4–20.9)</td>
                        <td align="center" rowspan="1" colspan="1">32.7 (26.4–40.4)</td>
                        <td align="center" rowspan="1" colspan="1">3.0 (1.5–6.0)</td>
                        <td align="center" rowspan="1" colspan="1">38.8 (32.1–46.8)</td>
                        <td align="center" rowspan="1" colspan="1">103.3 (92.1–115.9)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">3.8 (1.7–8.5)</td>
                        <td align="center" rowspan="1" colspan="1">19.1 (13.4–27.2)</td>
                        <td align="center" rowspan="1" colspan="1">37.6 (29.1–48.6)</td>
                        <td align="center" rowspan="1" colspan="1">3.8 (1.7–8.5)</td>
                        <td align="center" rowspan="1" colspan="1">38.8 (30.3–49.6)</td>
                        <td align="center" rowspan="1" colspan="1">98.2 (84.1–114.6)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">5.8 (3.0–11.1)</td>
                        <td align="center" rowspan="1" colspan="1">23.9 (17.4–32.8)</td>
                        <td align="center" rowspan="1" colspan="1">37.6 (29.0–48.6)</td>
                        <td align="center" rowspan="1" colspan="1">6.5 (3.5–12.0)</td>
                        <td align="center" rowspan="1" colspan="1">47.8 (38.2–59.6)</td>
                        <td align="center" rowspan="1" colspan="1">103.9 (89.4–120.7)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Age 70 or older</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">8.3 (6.0–11.5)</td>
                        <td align="center" rowspan="1" colspan="1">29.4 (24.8–34.9)</td>
                        <td align="center" rowspan="1" colspan="1">54.6 (48.0–62.0)</td>
                        <td align="center" rowspan="1" colspan="1">8.5 (6.2–11.7)</td>
                        <td align="center" rowspan="1" colspan="1">57.7 (51.2–65.1)</td>
                        <td align="center" rowspan="1" colspan="1">127.0 (117.2–137.6)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">10.2 (6.9–14.9)</td>
                        <td align="center" rowspan="1" colspan="1">29.7 (23.8–37.1)</td>
                        <td align="center" rowspan="1" colspan="1">54.1 (45.8–63.9)</td>
                        <td align="center" rowspan="1" colspan="1">10.9 (7.6–15.8)</td>
                        <td align="center" rowspan="1" colspan="1">53.6 (45.5–63.0)</td>
                        <td align="center" rowspan="1" colspan="1">119.0 (106.8–132.5)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">12.1 (8.5–17.2)</td>
                        <td align="center" rowspan="1" colspan="1">31.7 (25.6–39.2)</td>
                        <td align="center" rowspan="1" colspan="1">58.2 (49.6–68.2)</td>
                        <td align="center" rowspan="1" colspan="1">12.5 (8.9–17.7)</td>
                        <td align="center" rowspan="1" colspan="1">54.8 (46.6–64.3)</td>
                        <td align="center" rowspan="1" colspan="1">128.6 (115.8–142.6)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Non-smokers (former/never)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">6.3 (4.6–8.5)</td>
                        <td align="center" rowspan="1" colspan="1">24.0 (20.5–28.1)</td>
                        <td align="center" rowspan="1" colspan="1">45.8 (40.8–51.4)</td>
                        <td align="center" rowspan="1" colspan="1">6.4 (4.7–8.7)</td>
                        <td align="center" rowspan="1" colspan="1">50.0 (44.9–55.7)</td>
                        <td align="center" rowspan="1" colspan="1">118.0 (110.1–126.4)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">7.4 (5.1–10.8)</td>
                        <td align="center" rowspan="1" colspan="1">25.0 (20.4–30.5)</td>
                        <td align="center" rowspan="1" colspan="1">46.8 (40.3–54.2)</td>
                        <td align="center" rowspan="1" colspan="1">8.0 (5.6–11.4)</td>
                        <td align="center" rowspan="1" colspan="1">48.1 (41.7–55.4)</td>
                        <td align="center" rowspan="1" colspan="1">113.8 (103.9–124.7)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">10.4 (7.6–14.2)</td>
                        <td align="center" rowspan="1" colspan="1">26.6 (21.9–32.3)</td>
                        <td align="center" rowspan="1" colspan="1">49.4 (42.8–57.0)</td>
                        <td align="center" rowspan="1" colspan="1">11.2 (8.3–15.1)</td>
                        <td align="center" rowspan="1" colspan="1">50.6 (44.0–58.1)</td>
                        <td align="center" rowspan="1" colspan="1">119.2 (109.0–130.3)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Smokers (current)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">7.0 (3.7–13.4)</td>
                        <td align="center" rowspan="1" colspan="1">28.8 (21.0–39.6)</td>
                        <td align="center" rowspan="1" colspan="1">53.0 (41.6–67.3)</td>
                        <td align="center" rowspan="1" colspan="1">7.0 (3.7–13.4)</td>
                        <td align="center" rowspan="1" colspan="1">52.2 (41.3–65.9)</td>
                        <td align="center" rowspan="1" colspan="1">118.1 (101.0–137.7)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Amlodipine</td>
                        <td align="center" rowspan="1" colspan="1">5.2 (1.9–13.7)</td>
                        <td align="center" rowspan="1" colspan="1">23.3 (14.8–36.8)</td>
                        <td align="center" rowspan="1" colspan="1">47.8 (34.4–66.1)</td>
                        <td align="center" rowspan="1" colspan="1">5.2 (1.9–13.7)</td>
                        <td align="center" rowspan="1" colspan="1">50.5 (37.2–68.5)</td>
                        <td align="center" rowspan="1" colspan="1">98.3 (78.8–122.3)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">4.2 (1.3–12.8)</td>
                        <td align="center" rowspan="1" colspan="1">33.2 (22.4–49.2)</td>
                        <td align="center" rowspan="1" colspan="1">53.1 (38.7–72.6)</td>
                        <td align="center" rowspan="1" colspan="1">4.2 (1.3–12.8)</td>
                        <td align="center" rowspan="1" colspan="1">56.8 (42.1–76.3)</td>
                        <td align="center" rowspan="1" colspan="1">125.1 (102.3–152.5)</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t004fn001">
                    <p>*confidence interval could not be calculated</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p><xref rid="pone.0260107.t005" ref-type="table">Table 5</xref> presents the adjusted hazard ratios of GI bleeding for comparisons among 3 different trial arms as well as comparison among other factors. For example, as compared to those receiving chlorthalidone, patients who received amlodipine did not have a significantly different risk of developing GI bleeding [HR = 1.03, 95% CI: 0.87–1.22 from inpatient data, or 1.01 (0.90–1.14) from outpatient data]. The increased risk of GI bleeding by age was statistically significant after adjusting for confounders in the Cox regression models (HR = 1.04 per year increase, 95% CI: 1.03–1.05). Smokers also had a significantly higher risk of having hospitalized GI bleeding than those who did not (1.45, 1.19–1.76). Hispanics, those who used aspirin or atenolol at baseline, had diabetes, more education, and a history of MI or stroke had a significantly lower risk of having hospitalized GI bleeding than their counterparts, while only those who had diabetes had a significantly lower risk of having both hospitalized and non-hospitalized GI bleeding. Other factors such as gender, history of CHD, prior treatment of hypertension, use of estrogen in women, and obesity did not have significant effects on the risk of GI bleeding (<xref rid="pone.0260107.t005" ref-type="table">Table 5</xref>).</p>
              <table-wrap position="float" id="pone.0260107.t005">
                <object-id pub-id-type="doi">10.1371/journal.pone.0260107.t005</object-id>
                <label>Table 5</label>
                <caption>
                  <title>The effect of antihypertensive treatment on the risk of hospitalized GI bleeding, non-hospitalized GI bleeding, and combined GI bleeding adjusting for baseline characteristics and in-trial use of aspirin and atenolol.</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0260107.t005" id="pone.0260107.t005g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1">Covariates</th>
                        <th align="center" rowspan="1" colspan="1">HR<xref rid="t005fn001" ref-type="table-fn">*</xref> (95% CI) of Hospitalized GI Bleeding</th>
                        <th align="center" rowspan="1" colspan="1">HR<xref rid="t005fn001" ref-type="table-fn">*</xref> (95% CI) of Non-hospitalized GI Bleeding</th>
                        <th align="center" rowspan="1" colspan="1">HR<xref rid="t005fn001" ref-type="table-fn">*</xref> (95% CI) of Hospitalized or non-hospitalized GI Bleeding</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Amlodipine vs Chlorthalidone</td>
                        <td align="center" rowspan="1" colspan="1">1.03 (0.87–1.22)</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.90–1.14)</td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.88–1.10)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Amlodipine vs Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.82–1.21)</td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.85–1.10)</td>
                        <td align="center" rowspan="1" colspan="1">0.95 (0.84–1.07)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Chlorthalidone vs Lisinopril</td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.81–1.15)</td>
                        <td align="center" rowspan="1" colspan="1">0.95 (0.85–1.07)</td>
                        <td align="center" rowspan="1" colspan="1">0.96 (0.86–1.07)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Baseline aspirin use (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">1.07 (0.90–1.27)</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.90–1.14)</td>
                        <td align="center" rowspan="1" colspan="1">1.06 (0.96–1.19)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Aspirin ever use prior to GI bleeding (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.67 (0.55–0.80)</td>
                        <td align="center" rowspan="1" colspan="1">0.81 (0.72–0.92)</td>
                        <td align="center" rowspan="1" colspan="1">0.75 (0.67–0.84)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Baseline Atenolol (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.68 (0.41–1.10)</td>
                        <td align="center" rowspan="1" colspan="1">0.78 (0.58–1.06)</td>
                        <td align="center" rowspan="1" colspan="1">0.78 (0.59–1.03)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Atenolol ever use prior to GI bleeding (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.76 (0.62–0.93)</td>
                        <td align="center" rowspan="1" colspan="1">0.91 (0.80–1.03)</td>
                        <td align="center" rowspan="1" colspan="1">0.86 (0.76–0.97)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Age (per year)</td>
                        <td align="center" rowspan="1" colspan="1">1.04 (1.03–1.05)</td>
                        <td align="center" rowspan="1" colspan="1">1.02 (1.01–1.03)</td>
                        <td align="center" rowspan="1" colspan="1">1.02 (1.01–1.03)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Black (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.82–1.15)</td>
                        <td align="center" rowspan="1" colspan="1">1.11 (0.99–1.24)</td>
                        <td align="center" rowspan="1" colspan="1">1.08 (0.97–1.19)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Sex (male vs women)</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.90–1.22)</td>
                        <td align="center" rowspan="1" colspan="1">1.10 (0.99–1.22)</td>
                        <td align="center" rowspan="1" colspan="1">1.07 (0.97–1.18)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Hispanics (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.70 (0.56–0.87)</td>
                        <td align="center" rowspan="1" colspan="1">1.17 (1.03–1.34)</td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.92–1.19)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Smoker (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">1.45 (1.19–1.76)</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.87–1.16)</td>
                        <td align="center" rowspan="1" colspan="1">1.07 (0.94–1.22)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Education (per year)</td>
                        <td align="center" rowspan="1" colspan="1">0.96 (0.95–0.98)</td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.98–1.00)</td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.97–1.00)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Diabetes (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.64 (0.54–0.74)</td>
                        <td align="center" rowspan="1" colspan="1">0.88 (0.79–0.97)</td>
                        <td align="center" rowspan="1" colspan="1">0.83 (0.76–0.92)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">History of CHD (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.93 (0.76–1.15)</td>
                        <td align="center" rowspan="1" colspan="1">1.02 (0.89–1.18)</td>
                        <td align="center" rowspan="1" colspan="1">1.01 (0.88–1.15)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Atherosclerotic CVD (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.95 (0.75–1.21)</td>
                        <td align="center" rowspan="1" colspan="1">0.96 (0.82–1.13)</td>
                        <td align="center" rowspan="1" colspan="1">0.97 (0.83–1.12)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    History MI or stroke (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.77 (0.63–0.95)</td>
                        <td align="center" rowspan="1" colspan="1">0.93 (0.81–1.08)</td>
                        <td align="center" rowspan="1" colspan="1">0.88 (0.77–1.01)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Coronary revascularization (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.93 (0.73–1.19)</td>
                        <td align="center" rowspan="1" colspan="1">0.84 (0.71–0.99)</td>
                        <td align="center" rowspan="1" colspan="1">0.86 (0.74–1.01)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">    Other atherosclerotic CVD (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.87 (0.71–1.06)</td>
                        <td align="center" rowspan="1" colspan="1">0.92 (0.80–1.05)</td>
                        <td align="center" rowspan="1" colspan="1">0.89 (0.78–1.01)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">SBP (per mmHg)</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (1.00–1.01)</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (1.00–1.01)</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (1.00–1.00)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">DBP (per mmHg)</td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.98–1.00)</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.99–1.00)</td>
                        <td align="center" rowspan="1" colspan="1">1.00 (0.99–1.00)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Antihypertensive (treated vs no)</td>
                        <td align="center" rowspan="1" colspan="1">1.29 (0.97–1.72)</td>
                        <td align="center" rowspan="1" colspan="1">1.13 (0.94–1.36)</td>
                        <td align="center" rowspan="1" colspan="1">1.17 (0.99–1.40)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Women taking estrogen (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">0.77 (0.56–1.07)</td>
                        <td align="center" rowspan="1" colspan="1">1.14 (0.95–1.37)</td>
                        <td align="center" rowspan="1" colspan="1">1.06 (0.89–1.27)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">BMI (per BMI score)</td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.97–1.01)</td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.98–1.01)</td>
                        <td align="center" rowspan="1" colspan="1">0.99 (0.98–1.00)</td>
                      </tr>
                      <tr>
                        <td align="justify" rowspan="1" colspan="1">Obesity (yes vs no)</td>
                        <td align="center" rowspan="1" colspan="1">1.04 (0.82–1.31)</td>
                        <td align="center" rowspan="1" colspan="1">1.03 (0.88–1.20)</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.90–1.21)</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t005fn001">
                    <p>*HR (hazard ratio) was adjusted for other variables in the Table.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
            </sec>
            <sec sec-type="conclusions" id="sec014">
              <title>Discussion</title>
              <p>This study demonstrated that the risk of hospitalized GI bleeding was not significantly different among the ALLHAT trial arms (amlodipine, lisinopril, and chlorthalidone) during the entire in-trial follow-up period that ended by March 31, 2002. These findings were consistent with previous ALLHAT reports which were based on a shorter term of follow-up data from Medicare [<xref rid="pone.0260107.ref020" ref-type="bibr">20</xref>–<xref rid="pone.0260107.ref022" ref-type="bibr">22</xref>]. Moreover, our new analyses on the risk of non-hospitalized GI bleeding and combined all GI bleeding (hospitalized or non-hospitalized GI bleeding) also showed no statistically significant differences among the 3 trial arms. However, subgroups with older age and with smokers were found to be at a higher risk for GI bleeding, whereas patients who used aspirin or atenolol prior to the trial, Hispanics, those with diabetes, more education, and a history of MI or stroke had a significantly lower risk of having GI bleeding than their counterparts. The risk of GI bleeding did not significantly vary by gender, history of CHD, prior treatment of hypertension, use of estrogen in women, and obesity.</p>
              <p>We were able to have the data of ALLHAT trial participants linked with their Medicare claims data for the entire in-trial follow-up period through the Center for Medicare and Medicaid Services (CMS). Hence, our study was the only ALLHAT report with a complete follow-up information on the risk of GI bleeding during the entire in-trial period through March 31, 2002 and thus was able to capture all potential hospitalized GI bleeding events. All previous ALLHAT reports on GI bleeding were either based on a short follow-up data of Medicare data before [<xref rid="pone.0260107.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0260107.ref022" ref-type="bibr">22</xref>] or by September 24, 2001 [<xref rid="pone.0260107.ref022" ref-type="bibr">22</xref>]. Furthermore, all previous ALLHAT studies on GI bleeding were identified from inpatient hospitalization data only, and none of them had information on the GI bleeding identified from outpatient clinics or physician office visits. Our study was able to investigate relatively less severe GI bleeding events that did not lead to hospitalizations but were identified and treated in outpatient clinics or physician offices. Therefore, our report not only had complete follow-up information within the entire in-trial period but also reported for the first time the risk of GI bleeding from the outpatient data as well as the risk of GI bleeding among ALLHAT trial participants from the combined information from the inpatient and outpatient data. Moreover, our report corrected a few potential errors associated with the format of ICD-9 diagnosis coding and electronic codes in CMS datasets such as ‘05310’ versus ‘5310’ or ‘53100’, which might lead to a small misclassification bias on the study outcomes (see <xref rid="pone.0260107.s002" ref-type="supplementary-material">S1 Text</xref>). Therefore, our study findings added unique and insightful information to the existing literature on the findings of ALLHAT trial and should have important clinical and public health implications for the safety and side-effects of antihypertensive drugs, even though the study’s follow-up time was date back to March 2002.</p>
              <p>An early prospective community-based cohort study of 1636 hypertensive persons aged 68 years or older found that the use of calcium antagonists was associated with an increased risk of gastrointestinal hemorrhage with a relative risk of 1.86 (95% CI: 1.22–2.82) when compared with beta-blockers [<xref rid="pone.0260107.ref011" ref-type="bibr">11</xref>]. The similar finding was reported from a case-control study in Italy in 1998, in which the relative risk of GI bleeding associated with the current use of calcium channel blockers was 1.7 (95% CI: 1.3–2.1) [<xref rid="pone.0260107.ref012" ref-type="bibr">12</xref>]. A case-control in 1992–1994 from hypertensive patients from a Health Maintenance Organization group found that calcium channel blocker use was associated with a higher risk of lower GI tract bleeding, upper GI tract bleeding, and peptic ulcer-related bleeding [<xref rid="pone.0260107.ref013" ref-type="bibr">13</xref>]. Although three additional case-control studies also found a significant association between CCB use and the increased risk of GI bleeding [<xref rid="pone.0260107.ref023" ref-type="bibr">23</xref>–<xref rid="pone.0260107.ref025" ref-type="bibr">25</xref>], 6 other case-control studies did not find a significant association [<xref rid="pone.0260107.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0260107.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0260107.ref026" ref-type="bibr">26</xref>–<xref rid="pone.0260107.ref028" ref-type="bibr">28</xref>]. Furthermore, a nested case-control study within a population-based cohort of all 34,074 found no significant association between CCB and GI bleeding [<xref rid="pone.0260107.ref016" ref-type="bibr">16</xref>]. A retrospective cohort study among 105,824 enrollees of the Tennessee Medicaid program 65 years of age or older between 1984 and 1986 also found no increased risk for hospitalization with bleeding peptic ulcer among users of calcium channel blockers [<xref rid="pone.0260107.ref017" ref-type="bibr">17</xref>]. Previous ALLHAT reports [<xref rid="pone.0260107.ref020" ref-type="bibr">20</xref>–<xref rid="pone.0260107.ref022" ref-type="bibr">22</xref>] and our study using the latest complete information on the risk of GI bleeding had similar findings and confirmed that CCB was not associated with an increased risk of both hospitalized and non-hospitalized GI bleeding as compared to patients receiving diuretics or ACE-inhibitors. Three other trials also found no significant association between CCB and the risk of GI bleeding [<xref rid="pone.0260107.ref029" ref-type="bibr">29</xref>–<xref rid="pone.0260107.ref031" ref-type="bibr">31</xref>]. A meta-analysis of 17 studies showed a marginal association between CCB and an increased risk of GI bleeding [<xref rid="pone.0260107.ref032" ref-type="bibr">32</xref>], but this association was largely driven by the above 5 case-control studies [<xref rid="pone.0260107.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0260107.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0260107.ref023" ref-type="bibr">23</xref>–<xref rid="pone.0260107.ref025" ref-type="bibr">25</xref>] and a cohort study [<xref rid="pone.0260107.ref011" ref-type="bibr">11</xref>], whereas 6 other case-control studies [<xref rid="pone.0260107.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0260107.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0260107.ref026" ref-type="bibr">26</xref>–<xref rid="pone.0260107.ref028" ref-type="bibr">28</xref>], 1 cohort study [<xref rid="pone.0260107.ref018" ref-type="bibr">18</xref>], and 4 clinical trials [<xref rid="pone.0260107.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0260107.ref029" ref-type="bibr">29</xref>–<xref rid="pone.0260107.ref031" ref-type="bibr">31</xref>] did not find a significant association between CCB and the risk of GI bleeding.</p>
              <p>This study has several limitations. First, our report did not have long-term follow-up information on the risk of GI bleeding for Canadian and VA participants in ALLHAT because of lack of their Medicare claims data. Second, the ALLHAT trial participants who had GI bleeding regardless of its severity but did not go to the outpatient clinics or were not hospitalized were obviously not captured in this dataset, hence the study likely underestimated the risk of outcomes. Third, the study only addressed the risk of GI bleeding by the end of the in-trial period on March 31, 2002 that was about 18 years ago. Hence, the findings might have minimal impact on the current clinical practice. However, its assurance of the safety of calcium-channel blockers and the other two drugs (diuretics and ACE-inhibitors) in terms of GI bleeding may still be relevant to the clinical prescription of antihypertensive drugs for patients with hypertension. Further studies may be considered to have a longer follow-up by taking into consideration post-trial antihypertensive drug utilization and their changing drug patterns. Fourth, although we assumed that GI bleeding identified from outpatient clinics may be less severe than those identified from inpatient hospitalization data, it was not possible to determine its validity because Medicare claims data do not have details to differentiate them.</p>
              <p>In conclusion, there were no statistically significant differences in the risk of hospitalized GI bleeding and combined all GI bleeding (hospitalized or non-hospitalized GI bleeding) among the 3 ALLHAT trial arms (amlodipine, lisinopril, and chlorthalidone) during the entire in-trial follow-up that ended by March 31, 2002. However, subgroups with older age and with smokers were found to be at a higher risk for GI bleeding, whereas patients with prior aspirin or atenolol use in-trial, Hispanics, those with diabetes, more education, and a history of MI or stroke had a significantly lower risk of having GI bleeding than their counterparts. The findings should have clinical and public health implications on the safety and choices of these antihypertensive drugs by physicians and patients with hypertension.</p>
            </sec>
            <sec id="sec015" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0260107.s001" position="float" content-type="local-data">
                <label>S1 Table</label>
                <caption>
                  <title>ICD-9 and ICD-10 codes for GI bleeding.</title>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0260107.s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0260107.s002" position="float" content-type="local-data">
                <label>S1 Text</label>
                <caption>
                  <title>Statistical programs and models.</title>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0260107.s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We thank Charles Coton for his participation and data management and analytical support for the study.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0260107.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Staessen</surname><given-names>JA</given-names></name>, <name><surname>Fagard</surname><given-names>R</given-names></name>, <name><surname>Thijs</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Randomised double‐blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (SYST‐EUR) trial investigators.</article-title><source>Lancet</source>. <year>1997</year>;<volume>350</volume>:<fpage>757</fpage>–<lpage>764</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0140-6736(97)05381-6</pub-id>
<?supplied-pmid 9297994?><pub-id pub-id-type="pmid">9297994</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Rosei</surname><given-names>EA</given-names></name>, <name><surname>Dal Palu</surname><given-names>C</given-names></name>, <name><surname>Leonetti</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Clinical results of the Verapamil in Hypertension and Atherosclerosis Study. VHAS investigators</article-title>. <source>J Hypertens</source>. <year>1997</year>;<volume>15</volume>:<fpage>1337</fpage>–<lpage>1344</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/00004872-199715110-00019</pub-id>
<?supplied-pmid 9383184?><pub-id pub-id-type="pmid">9383184</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Staessen</surname><given-names>JA</given-names></name>, <name><surname>Fagard</surname><given-names>R</given-names></name>, <name><surname>Thijs</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly</article-title>. <source>Arch Intern Med</source>. <year>1998</year>;<volume>158</volume>(<issue>15</issue>):<fpage>1681</fpage>–<lpage>91</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/archinte.158.15.1681</pub-id>
<?supplied-pmid 9701103?><pub-id pub-id-type="pmid">9701103</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Hansson</surname><given-names>L</given-names></name>, <name><surname>Zanchetti</surname><given-names>A</given-names></name>, <name><surname>Carruthers</surname><given-names>SG</given-names></name>, <etal>et al</etal>. <article-title>Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) Randomised Trial. HOT study group</article-title>. <source>Lancet</source>. <year>1998</year>;<volume>351</volume>:<fpage>1755</fpage>–<lpage>1762</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0140-6736(98)04311-6</pub-id>
<?supplied-pmid 9635947?><pub-id pub-id-type="pmid">9635947</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Tuomilehto</surname><given-names>J</given-names></name>, <name><surname>Rastenyte</surname><given-names>D</given-names></name>, <name><surname>Birkenhäger</surname><given-names>WH</given-names></name>, <etal>et al</etal>. <article-title>Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators</article-title>. <source>N Engl J Med</source>. <year>1999</year>;<volume>340</volume>(<issue>9</issue>):<fpage>677</fpage>–<lpage>84</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJM199903043400902</pub-id>
<?supplied-pmid 10053176?><pub-id pub-id-type="pmid">10053176</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Hansson</surname><given-names>L</given-names></name>, <name><surname>Lindholm</surname><given-names>LH</given-names></name>, <name><surname>Ekbom</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with hypertension‐2 study</article-title>. <source>Lancet</source>. <year>1999</year>;<volume>354</volume>:<fpage>1751</fpage>–<lpage>1756</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0140-6736(99)10327-1</pub-id>
<?supplied-pmid 10577635?><pub-id pub-id-type="pmid">10577635</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Brown</surname><given-names>MJ</given-names></name>, <name><surname>Palmer</surname><given-names>CR</given-names></name>, <name><surname>Castaigne</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Morbidity and mortality in patients randomised to double‐blind treatment with a long‐acting calcium‐channel blocker or diuretic in the international nifedipine GITS study: intervention as a Goal In Hypertension Treatment (INSIGHT).</article-title><source>Lancet</source>. <year>2000</year>;<volume>356</volume>:<fpage>366</fpage>–<lpage>372</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(00)02527-7</pub-id>
<?supplied-pmid 10972368?><pub-id pub-id-type="pmid">10972368</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Hansson</surname><given-names>L</given-names></name>, <name><surname>Hedner</surname><given-names>T</given-names></name>, <name><surname>Lund‐Johansen</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Randomised trial of effects of calcium antagonists compared with diuretics and beta‐blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study</article-title>. <source>Lancet</source>. <year>2000</year>;<volume>356</volume>:<fpage>359</fpage>–<lpage>365</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0140-6736(00)02526-5</pub-id>
<?supplied-pmid 10972367?><pub-id pub-id-type="pmid">10972367</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Staessen</surname><given-names>JA</given-names></name>, <name><surname>Thijs</surname><given-names>L</given-names></name>, <name><surname>Celis</surname><given-names>H</given-names></name>, <name><surname>Gasowski</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>JG</given-names></name>, <name><surname>Fagard</surname><given-names>RH</given-names></name><article-title>; Systolic Hypertension in Europe Trial Investigators (the Syst-Eur Trial). Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients—evidence from the Systolic Hypertension in Europe Trial</article-title>. <source>S Afr Med J</source>. <year>2001</year>;<volume>91</volume>(<issue>12</issue>):<fpage>1060</fpage>–<lpage>8</lpage>. <?supplied-pmid 11845604?><pub-id pub-id-type="pmid">11845604</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Black</surname><given-names>HR</given-names></name>, <name><surname>Elliott</surname><given-names>WJ</given-names></name>, <name><surname>Grandits</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) trial.</article-title><source>JAMA</source>. <year>2003</year>;<volume>289</volume>:<fpage>2073</fpage>–<lpage>2082</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.289.16.2073</pub-id>
<?supplied-pmid 12709465?><pub-id pub-id-type="pmid">12709465</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Pahor</surname><given-names>M</given-names></name>, <name><surname>Guralnik</surname><given-names>JM</given-names></name>, <name><surname>Furberg</surname><given-names>CD</given-names></name>, <etal>et al</etal>. <article-title>Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old</article-title>. <source>Lancet</source>. <year>1996</year>;<volume>347</volume>:<fpage>1061</fpage>–<lpage>1065</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0140-6736(96)90276-7</pub-id>
<?supplied-pmid 8602055?><pub-id pub-id-type="pmid">8602055</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Garcia Rodriguez</surname><given-names>LA</given-names></name>, <name><surname>Cattaruzzi</surname><given-names>C</given-names></name>, <name><surname>Troncon</surname><given-names>MG</given-names></name>, <name><surname>Agostinis</surname><given-names>L</given-names></name>. <article-title>Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs</article-title>. <source>Arch Intern Med</source>. <year>1998</year>;<volume>158</volume>:<fpage>33</fpage>–<lpage>39</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/archinte.158.1.33</pub-id>
<?supplied-pmid 9437376?><pub-id pub-id-type="pmid">9437376</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Kaplan</surname><given-names>RC</given-names></name>, <name><surname>Heckbert</surname><given-names>SR</given-names></name>, <name><surname>Koepsell</surname><given-names>TD</given-names></name>, <name><surname>Rosendaal</surname><given-names>FR</given-names></name>, <name><surname>Psaty</surname><given-names>BM</given-names></name>. <article-title>Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding</article-title>. <source>Arch Intern Med</source>. <year>2000</year>;<volume>160</volume>:<fpage>1849</fpage>–<lpage>1855</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/archinte.160.12.1849</pub-id>
<?supplied-pmid 10871980?><pub-id pub-id-type="pmid">10871980</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Zuccala</surname><given-names>G</given-names></name>, <name><surname>Pedone</surname><given-names>C</given-names></name>, <name><surname>Cocchi</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Use of calcium antagonists and hemoglobin loss in hospitalized elderly patients: a cohort study. Gruppo Italiano di Farmacoepidemiologia nell’Anziano (GIFA) Investigators.</article-title><source>Clin Pharmacol Ther</source>. <year>2000</year>;<volume>67</volume>:<fpage>314</fpage>–<lpage>322</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1067/mcp.2000.104787</pub-id>
<?supplied-pmid 10741636?><pub-id pub-id-type="pmid">10741636</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Pilotto</surname><given-names>A</given-names></name>, <name><surname>Leandro</surname><given-names>G</given-names></name>, <name><surname>Franceschi</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Antagonism to calcium antagonists</article-title>. <source>Lancet</source>. <year>1996</year>;<volume>347</volume>:<fpage>1761</fpage>–<lpage>1762</lpage>. <?supplied-pmid 8656917?><pub-id pub-id-type="pmid">8656917</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Suissa</surname><given-names>S</given-names></name>, <name><surname>Bourgault</surname><given-names>C</given-names></name>, <name><surname>Barkun</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Antihypertensive drugs and the risk of gastrointestinal bleeding</article-title>. <source>Am J Med</source>. <year>1998</year>;<volume>105</volume>:<fpage>230</fpage>–<lpage>235</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0002-9343(98)00239-3</pub-id>
<?supplied-pmid 9753026?><pub-id pub-id-type="pmid">9753026</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Kelly</surname><given-names>JP</given-names></name>, <name><surname>Laszlo</surname><given-names>A</given-names></name>, <name><surname>Kaufman</surname><given-names>DW</given-names></name>, <etal>et al</etal>. <article-title>Major upper gastrointestinal bleeding and the use of calcium channel blockers</article-title>. <source>Lancet</source>. <year>1999</year>;<volume>353</volume>:<fpage>559</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(98)05202-7</pub-id><?supplied-pmid 10028991?><pub-id pub-id-type="pmid">10028991</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Smalley</surname><given-names>WE</given-names></name>, <name><surname>Ray</surname><given-names>WA</given-names></name>, <name><surname>Daugherty</surname><given-names>JR</given-names></name>, <name><surname>Griffin</surname><given-names>MR</given-names></name>. <article-title>No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease</article-title>. <source>Am J Epidemiol</source>. <year>1998</year>;<volume>148</volume>:<fpage>350</fpage>–<lpage>354</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a009652</pub-id>
<?supplied-pmid 9717878?><pub-id pub-id-type="pmid">9717878</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Kaplan</surname><given-names>RC</given-names></name>, <name><surname>Heckbert</surname><given-names>SR</given-names></name>, <name><surname>Koepsell</surname><given-names>TD</given-names></name>, <etal>et al</etal>. <article-title>Calcium channel blocker use and gastrointestinal tract bleeding among older adults.</article-title><source>Age Ageing</source>. <year>2002</year>;<volume>31</volume>:<fpage>217</fpage>–<lpage>218</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ageing/31.3.217</pub-id>
<?supplied-pmid 12006312?><pub-id pub-id-type="pmid">12006312</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><collab>ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group</collab>. <article-title>The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).</article-title><source>JAMA</source>. <year>2002</year>;<volume>288</volume>(<issue>23</issue>):<fpage>2981</fpage>–<lpage>97</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.288.23.2981</pub-id>
<?supplied-pmid 12479763?><pub-id pub-id-type="pmid">12479763</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Leenen</surname><given-names>FH</given-names></name>, <name><surname>Nwachuku</surname><given-names>CE</given-names></name>, <name><surname>Black</surname><given-names>HR</given-names></name>, <etal>et al</etal>. <article-title>Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial</article-title>. <source>Hypertension</source>. <year>2006</year>;<volume>48</volume>(<issue>3</issue>):<fpage>374</fpage>–<lpage>84</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/01.HYP.0000231662.77359.de</pub-id>
<?supplied-pmid 16864749?><pub-id pub-id-type="pmid">16864749</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Phillips</surname><given-names>W</given-names></name>, <name><surname>Piller</surname><given-names>LB</given-names></name>, <name><surname>Williamson</surname><given-names>JD</given-names></name>, <etal>et al</etal>; <collab>ALLHAT Collaborative Research Group</collab>. <article-title>Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.</article-title><source>J Clin Hypertens (Greenwich)</source>. <year>2013</year>;<volume>15</volume>(<issue>11</issue>):<fpage>825</fpage>–<lpage>32</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/jch.12180</pub-id>
<?supplied-pmid 24283598?><pub-id pub-id-type="pmid">24283598</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Yamada</surname><given-names>A</given-names></name>, <name><surname>Sugimoto</surname><given-names>T</given-names></name>, <name><surname>Kondo</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Assessment of the risk factors for colonic diverticular hemorrhage</article-title>. <source>Dis Colon Rectum</source>. <year>2008</year>;<volume>51</volume>:<fpage>116</fpage>–<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10350-007-9137-8</pub-id>
<?supplied-pmid 18085336?><pub-id pub-id-type="pmid">18085336</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Jansen</surname><given-names>A</given-names></name>, <name><surname>Harenberg</surname><given-names>S</given-names></name>, <name><surname>Grenda</surname><given-names>U</given-names></name>, <name><surname>Elsing</surname><given-names>C</given-names></name>. <article-title>Risk factors for colonic diverticular bleeding: a Westernized community based hospital study</article-title>. <source>World J Gastroenterol</source><year>2009</year>;<volume>15</volume>:<fpage>457</fpage>–<lpage>61</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3748/wjg.15.457</pub-id>
<?supplied-pmid 19152450?><pub-id pub-id-type="pmid">19152450</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Suh</surname><given-names>S</given-names></name>, <name><surname>Seo</surname><given-names>PJ</given-names></name>, <name><surname>Park</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>The risk factors for colonic diverticular bleeding</article-title>. <source>Korean J Gastroenterol</source>. <year>2012</year>;<volume>60</volume>:<fpage>349</fpage>–<lpage>54</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4166/kjg.2012.60.6.349</pub-id>
<?supplied-pmid 23242017?><pub-id pub-id-type="pmid">23242017</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Weil</surname><given-names>J</given-names></name>, <name><surname>Langman</surname><given-names>MJ</given-names></name>, <name><surname>Wainwright</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Peptic ulcer bleeding: accessory risk factors and interactions with nonsteroidal anti-inflammatory drugs</article-title>. <source>Gut</source>. <year>2000</year>;<volume>46</volume>:<fpage>27</fpage>–<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/gut.46.1.27</pub-id>
<?supplied-pmid 10601050?><pub-id pub-id-type="pmid">10601050</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Lanas</surname><given-names>A</given-names></name>, <name><surname>Serrano</surname><given-names>P</given-names></name>, <name><surname>Bajador</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs</article-title>. <source>Eur J Gastroenterol Hepatol</source>. <year>2003</year>;<volume>15</volume>:<fpage>173</fpage>–<lpage>178</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/00042737-200302000-00011</pub-id>
<?supplied-pmid 12560762?><pub-id pub-id-type="pmid">12560762</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Nagata</surname><given-names>N</given-names></name>, <name><surname>Niikura</surname><given-names>R</given-names></name>, <name><surname>Sekine</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2015</year>;<volume>30</volume>:<fpage>292</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/jgh.12805</pub-id>
<?supplied-pmid 25339607?><pub-id pub-id-type="pmid">25339607</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Petruk</surname><given-names>KC</given-names></name>, <name><surname>West</surname><given-names>M</given-names></name>, <name><surname>Mohr</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebocontrolled trial.</article-title><source>J Neurosurg</source>. <year>1988</year>;<volume>68</volume>:<fpage>505</fpage>–<lpage>17</lpage>. (these 3 RCTs compared CCBs with placebo and found no sig association with risk of GI bleeding) <comment>doi: </comment><pub-id pub-id-type="doi">10.3171/jns.1988.68.4.0505</pub-id>
<?supplied-pmid 3280746?><pub-id pub-id-type="pmid">3280746</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Celis</surname><given-names>H</given-names></name>, <name><surname>Thijs</surname><given-names>L</given-names></name>, <name><surname>Staessen</surname><given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Interaction between nonsteroidal antiinflammatory drug intake and calciumchannel blocker-based antihypertensive treatment in the Syst-Eur trial.</article-title><source>J Hum Hypertens</source>. <year>2001</year>;<volume>15</volume>:<fpage>613</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/sj.jhh.1001235</pub-id>
<?supplied-pmid 11550107?><pub-id pub-id-type="pmid">11550107</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name>, <name><surname>Kirwan</surname><given-names>BA</given-names></name>, <name><surname>Voko</surname><given-names>Z</given-names></name>, <name><surname>de Brouwer</surname><given-names>S</given-names></name>, <name><surname>van Dalen</surname><given-names>FJ</given-names></name>, <name><surname>Lubsen</surname><given-names>J</given-names></name>. <article-title>Safety of nifedipine GITS in stable angina: the ACTION trial.</article-title><source>Cardiovasc Drugs Ther</source>. <year>2006</year>;<volume>20</volume>:<fpage>45</fpage>–<lpage>54</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10557-006-6312-4</pub-id>
<?supplied-pmid 16552473?><pub-id pub-id-type="pmid">16552473</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0260107.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>He</surname><given-names>Y</given-names></name>, <name><surname>Chan</surname><given-names>EW</given-names></name>, <name><surname>Leung</surname><given-names>WK</given-names></name>, <name><surname>Anand</surname><given-names>S</given-names></name>, <name><surname>Wong</surname><given-names>IC</given-names></name>. <article-title>Systematic review with meta-analysis: the association between the use of calcium channel blockers and gastrointestinal bleeding</article-title>. <source>Aliment Pharmacol Ther</source>. <year>2015</year>;<volume>41</volume>(<issue>12</issue>):<fpage>1246</fpage>–<lpage>55</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/apt.13211</pub-id>
<?supplied-pmid 25898902?><pub-id pub-id-type="pmid">25898902</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
          <sub-article article-type="aggregated-review-documents" id="pone.0260107.r001" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0260107.r001</article-id>
              <title-group>
                <article-title>Decision Letter 0</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wright</surname>
                    <given-names>James M</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 James M Wright</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>James M Wright</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0260107" id="rel-obj001" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>0</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">22 Jul 2021</named-content>
              </p>
              <p>PONE-D-21-20128</p>
              <p>Risk of  hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker</p>
              <p>PLOS ONE</p>
              <p>Dear Dr. Xianglin L Du,</p>
              <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
              <p>Please respond to each of the points made by reviewer 1 below.  </p>
              <p>Please submit your revised manuscript by Sep 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
              <p>Please include the following items when submitting your revised manuscript:</p>
              <p>
                <list list-type="bullet">
                  <list-item>
                    <p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p>
                  </list-item>
                  <list-item>
                    <p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p>
                  </list-item>
                  <list-item>
                    <p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p>
                  </list-item>
                </list>
              </p>
              <p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
              <p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p>
              <p>We look forward to receiving your revised manuscript.</p>
              <p>Kind regards,</p>
              <p>James M Wright</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Journal Requirements:</p>
              <p>When submitting your revision, we need you to address these additional requirements.</p>
              <p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
              <p><underline><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link></underline> and</p>
              <p>
                <ext-link xlink:href="about:blank" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
              </p>
              <p>2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
              <p>3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see <ext-link xlink:href="http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions" ext-link-type="uri">http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions</ext-link>.</p>
              <p>In your revised cover letter, please address the following prompts:</p>
              <p>a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.</p>
              <p>b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see <ext-link xlink:href="http://www.bmj.com/content/340/bmj.c181.long" ext-link-type="uri">http://www.bmj.com/content/340/bmj.c181.long</ext-link> for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see <ext-link xlink:href="http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories" ext-link-type="uri">http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories</ext-link>.</p>
              <p>We will update your Data Availability statement on your behalf to reflect the information you provide.</p>
              <p>4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <ext-link xlink:href="about:blank" ext-link-type="uri">http://journals.plos.org/plosone/s/supporting-information</ext-link>.</p>
              <p>5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.</p>
              <p>[Note: HTML markup is below. Please do not edit.]</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <bold>Comments to the Author</bold>
              </p>
              <p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p>2. Has the statistical analysis been performed appropriately and rigorously? </p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: I Don't Know</p>
              <p>**********</p>
              <p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p>5. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
              <p>Reviewer #1: This is a useful study that further adds to the analysis of the ALLHAT study, showing that there is no significant difference between the antihypertensive medications used in the 3 arms of the trial regarding the incidence of GI bleeding. Through the use linked ALLHAT participant Medicare claims data taken to the end of the study, the authors were able to conduct a data linkage analysis that supports the conclusion about GI bleeding and the conclusion that age and smoking is associated to increased risk of GI bleeding while other factors are associated with reduced risk of GI bleeding. While conclusions drawn from the ALLHAT trial and accompanying analyses will always be limited by the rapidly updating clinical evidence, this study is important in expanding our understanding of the results of the trial for better completeness and for reviews of the existing evidence.</p>
              <p>Major concerns</p>
              <p>1. In Data Availability, relevant to the Methods section, the authors state “We plan to share the statistical models and statistical programs that we sued to analyze these data upon request”. The statistical programs and the versions used for the Kaplan-Meier method and the Cox regression models should be provided at the very least in the Statistical analysis section found on page 7.</p>
              <p>Minor concerns</p>
              <p>1. Authors state that the smoking group are at increased risk of GI bleed, and this is supported in Table 5 but only for hospitalized GI bleeding, it should be specified in the Results page 10 second paragraph “Smokers also had a significantly higher risk of having GI bleeding than those who did not” should be “Smokers also had a significantly higher risk of having hospitalized GI bleeding than those who did not”. Page 2 Results paragraph “Smokers also had a significantly higher risk of having GI bleeding” should be “Smokers also had a significantly higher risk of having hospitalized GI bleeding”.</p>
              <p>2. The generalized conclusion statements about the relevance of this study for its clinical significance should be more specific. Page 5 first paragraph “Hence, the findings of this study should have high public health and clinical significance in terms of overall side effects and routine intake of antihypertensive drugs” should be “Hence, the findings of this study should have high public health and clinical significance with respect to GI bleeding and routine intake of antihypertensive drugs”. Page 12 paragraph one, line 4 “health implications for the safety and side-effects of antihypertensive drugs,” should be “health implications for the safety and side effects of antihypertensive drugs regarding GI bleeding,”</p>
              <p>3. Minor grammatical clarification on page 12, paragraph one, line 5 “study’s follow-up time was back to March 2002.” should be “study’s follow-up time was dated back to March 2002.”</p>
              <p>Reviewer #2: This is a very clear and simple study with important conclusions. I am not competent to judge the statistical methods used, but the study description, patient characteristics and findings, including limitations are all presented clearly and completely.</p>
              <p>It should be published without any revisions.</p>
              <p>**********</p>
              <p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
              <p>Reviewer #1: No</p>
              <p>Reviewer #2: No</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
            </body>
          </sub-article>
          <sub-article article-type="author-comment" id="pone.0260107.r002">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0260107.r002</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 0</article-title>
              </title-group>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0260107" id="rel-obj002" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">20 Oct 2021</named-content>
              </p>
              <p>Responses to the reviewer’s comments on a point-by-point basis. </p>
              <p>Reviewer #1: This is a useful study that further adds to the analysis of the ALLHAT study, showing that there is no significant difference between the antihypertensive medications used in the 3 arms of the trial regarding the incidence of GI bleeding. Through the use linked ALLHAT participant Medicare claims data taken to the end of the study, the authors were able to conduct a data linkage analysis that supports the conclusion about GI bleeding and the conclusion that age and smoking is associated to increased risk of GI bleeding while other factors are associated with reduced risk of GI bleeding. While conclusions drawn from the ALLHAT trial and accompanying analyses will always be limited by the rapidly updating clinical evidence, this study is important in expanding our understanding of the results of the trial for better completeness and for reviews of the existing evidence.</p>
              <p>Major concerns</p>
              <p>1. In Data Availability, relevant to the Methods section, the authors state “We plan to share the statistical models and statistical programs that we sued to analyze these data upon request”. The statistical programs and the versions used for the Kaplan-Meier method and the Cox regression models should be provided at the very least in the Statistical analysis section found on page 7.</p>
              <p>Response: As suggested, we have added our statistical programs for the Kaplan-Meier estimates on the cumulative incidence of GI bleeding and the Cox regressions on the hazard ratio of GI bleeding in the “Data Availability” section. </p>
              <p>Minor concerns</p>
              <p>1. Authors state that the smoking group are at increased risk of GI bleed, and this is supported in Table 5 but only for hospitalized GI bleeding, it should be specified in the Results page 10 second paragraph “Smokers also had a significantly higher risk of having GI bleeding than those who did not” should be “Smokers also had a significantly higher risk of having hospitalized GI bleeding than those who did not”. Page 2 Results paragraph “Smokers also had a significantly higher risk of having GI bleeding” should be “Smokers also had a significantly higher risk of having hospitalized GI bleeding”.</p>
              <p>Response: Thank you for helpful suggestions. We have made these two changes as suggested.</p>
              <p>2. The generalized conclusion statements about the relevance of this study for its clinical significance should be more specific. Page 5 first paragraph “Hence, the findings of this study should have high public health and clinical significance in terms of overall side effects and routine intake of antihypertensive drugs” should be “Hence, the findings of this study should have high public health and clinical significance with respect to GI bleeding and routine intake of antihypertensive drugs”. Page 12 paragraph one, line 4 “health implications for the safety and side-effects of antihypertensive drugs,” should be “health implications for the safety and side effects of antihypertensive drugs regarding GI bleeding,”</p>
              <p>Response: Thank you for helpful suggestion. We have made this change as suggested on page 5. </p>
              <p>3. Minor grammatical clarification on page 12, paragraph one, line 5 “study’s follow-up time was back to March 2002.” should be “study’s follow-up time was dated back to March 2002.”</p>
              <p>Response: Thank you for helpful suggestion. We have made this change as suggested on page 12.</p>
              <p>Reviewer #2: This is a very clear and simple study with important conclusions. I am not competent to judge the statistical methods used, but the study description, patient characteristics and findings, including limitations are all presented clearly and completely.</p>
              <p>It should be published without any revisions.</p>
              <p>Response: Thank you so much for positive comments!</p>
              <supplementary-material id="pone.0260107.s003" position="float" content-type="local-data">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">Response to reviewers (PlosOne).docx</named-content></p>
                </caption>
                <media xlink:href="pone.0260107.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article article-type="editor-report" id="pone.0260107.r003" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0260107.r003</article-id>
              <title-group>
                <article-title>Decision Letter 1</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wright</surname>
                    <given-names>James M</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 James M Wright</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>James M Wright</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0260107" id="rel-obj003" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">3 Nov 2021</named-content>
              </p>
              <p>Risk of  hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker</p>
              <p>PONE-D-21-20128R1</p>
              <p>Dear Dr. Xianglin L. Du: </p>
              <p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
              <p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
              <p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link xlink:href="http://www.editorialmanager.com/pone/" ext-link-type="uri">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p>
              <p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
              <p>Kind regards,</p>
              <p>James M Wright</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Additional Editor Comments (optional):</p>
              <p>Reviewers' comments:</p>
            </body>
          </sub-article>
          <sub-article article-type="editor-report" id="pone.0260107.r004" specific-use="acceptance-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0260107.r004</article-id>
              <title-group>
                <article-title>Acceptance letter</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wright</surname>
                    <given-names>James M</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 James M Wright</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>James M Wright</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0260107" id="rel-obj004" related-article-type="reviewed-article"/>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">8 Nov 2021</named-content>
              </p>
              <p>PONE-D-21-20128R1 </p>
              <p>Risk of  hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker </p>
              <p>Dear Dr. Du:</p>
              <p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p>
              <p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p>
              <p>If we can help with anything else, please email us at <email>plosone@plos.org</email>. </p>
              <p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
              <p>Kind regards, </p>
              <p>PLOS ONE Editorial Office Staff</p>
              <p>on behalf of</p>
              <p>Professor James M Wright </p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
            </body>
          </sub-article>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
